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Abstract 
 
Dopamine is one of the central neurotransmitters; its homeostatic 
concentration is highly maintained through release, uptake, and feedback. 
 The dopamine release is mediated both presynaptic and postsynaptic mechanisms. 
The extracellular dopamine concentration is regulated presynaptically by the 
dopamine transporter and dopamine autoreceptors. The postsynaptic control is 
mediated by postsynaptic dopamine receptors.  
 Dopamine is the subject of a numerous experimental studies. As a result, a 
great deal of experimental data describing the components of dopamine system has 
been collected. This experimental data provides an excellent foundation for 
theoretical study to model complex dopamine system. The integration of a  
published experimental data in one theoretical model would be a valuable tool to 
describe the dopamine system and generate better understanding of the complex 
process of the dopamine concentration control.    
The object of this thesis was to develop a computational system describing 
the behavior of the complex extracellular dopamine concentration control system.  
There are two principal processes of the dopamine concentration control: uptake 
and negative feedback.  The novelty of the presented modeling work is that it 
integrates the dopamine concentration control by uptake and negative feedback in a 
single computational model. 
 The proposed model was used to evaluate the contribution of kinetic and 
feedback mechanisms to maintain low basal dopamine concentration; test the 
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 extracellular dopamine concentration outcomes under conditions of 
increased/decreased dopamine release; and predict changes in extracellular 
dopamine concentration under conditions equivalent to the presence of dopamine 
agonist/antagonists in the experimental dopamine system. 
Mathematical modeling was based on published pharmacokinetic parameters 
for dopamine uptake and receptor binding in rat striatum, and  the computational 
data generated by thesis developed models.  
The mathematical modeling results showed that the computational 
extracellular dopamine concentration outcomes were consistent with the 
experimentally observed responses for the dopamine system. It was demonstrated 
computationally that both uptake by DAT and negative feedback mediated by 
receptors are necessary components to maintain a low extracellular dopamine 
concentration under basal conditions. The mathematical modeling showed the 
critical role of negative feedback to control stable extracellular dopamine 
concentration under conditions of increased/decreased dopamine release. The 
model generated results predicting extracellular dopamine concentration change 
under conditions equivalent to the presence of dopamine agonist/antagonist were in 
a good accordance with published experimental data.   
In addition to the mathematical modeling, programming, and computational 
analysis, the value of this work is demonstrated through its ability to illustrate how 
integration of published experimental and model simulated data provides an 
excellent foundation for computational theoretical research.   
   XII 
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ABSTRACT 
 
Dopamine is one of the central neurotransmitters; its homeostatic 
concentration is highly maintained through release and re-uptake. Dopamine 
release is mediated at presynaptic vesicles and controlled by dopamine 
receptors. Dopamine release regulation by dopamine receptors is mediated by 
negative feedback. This negative feedback is a function of dopamine receptor 
occupancy by dopamine or dopamine agonists.  Dopamine re-uptake is regulated 
presynaptically by Dopamine Transporter (DAT).  
The object of this study was to develop a computational system to 
describe and predict the behavior of the complex process of extracellular 
dopamine concentration control. The uniqueness and advantage of presented 
modeling work is that it models extracellular dopamine concentration control as a 
complex of both re-uptake and feedback mechanisms.  
Mathematical modeling was based on published pharmacokinetic 
parameters for dopamine re-uptake and binding in rat striatum, and 
computational data generated by presented study. The dopamine system 
modeling was conducted for the following conditions:  
 
• basal conditions;  
• increased/decreased dopamine release;  
• presence of dopamine agonist/antagonist in the system.  
 
 1
Results of mathematical modeling showed that proposed computational 
model is successfully predicting outcomes of complex extracellular dopamine 
concentration control system. It was demonstrated computationally that both  
re-uptake by dopamine transporter and negative feedback mediated by receptors 
are necessary components to maintain low, nM, extracellular dopamine 
concentration under basal conditions. Mathematical modeling demonstrated the 
critical role of feedback to maintain stable extracellular dopamine concentration 
under conditions of increased/decreased dopamine release. The model-
generated results predicting extracellular dopamine concentration change under 
conditions equivalent to the presence of dopamine agonist/antagonist were in 
good accordance with published experimental data.   
In addition to the mathematical modeling and computational programming, 
the value of this thesis work is that it demonstrates how data mining and  
computational conclusions can be done based on the integration of the results 
from independent experimental studies. A strong trend in the modern bioscience 
is a computational analysis based on data generated by biological research. This 
thesis work is an example of successful biological system modeling based on 
published experimental data. 
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1. INTRODUCTION 
 
1.1 DOPAMINERGIC SYSTEM OVERVIEW  
 
1.1.1   Dopamine and Dopamine Receptors 
 
The aim of this thesis was to develop the computational model for the 
dopamine concentration control integrating dopamine release, dopamine uptake, 
and negative feedback mechanisms.  
Of many neurotransmitters that have been discovered over the years, 
dopamine (DA) has been found to be a common link in many neurological 
disorders in central nervous system. Dopamine is a catecholamine 
neurotransmitter. In a mammalian brain, dopamine controls a variety of functions 
including locomotor activity, cognition, emotion, food intake, and endocrine 
regulation. This catecholamine also plays multiple roles in the periphery as a 
modulator of a cardiovascular function, hormone secretion, renal function, and 
gastrointestinal motility. The interest in the study of dopamine receptors was 
promoted by observations that  disbalance in dopamine concentration is a 
principal condition responsible for certain brain diseases such as Parkinson’s 
disease and schizophrenia [4, 15, 30, 61, 66]. Schizophrenia, for example, is a 
form of mental illness that is thought to develop as a result of an abnormal 
excessive dopamine neurotransmission in the brain. Antipsychotic drugs 
(neuroleptics) antagonize the action of dopamine by decreasing postsynaptic 
dopamine concentration. Dopamine is also considered to be a major 
neurobiological substrate of the addictive properties of drug abuse.  
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 Almost all drugs of abuse share the common feature of increasing extracellular 
concentration of dopamine in striatal complex [48, 76].    
The release of the extracellular dopamine into synaptic cleft is a 
determinant event in dopaminergic neurotransmission. Dopaminergic 
neurotransmission is a complex and highly controlled process. Dopamine release 
is calcium and impulse flow dependent.  As with other neurotransmitters, 
dopamine communicates with cells through dopamine receptors. Unlike many 
neurotransmitters, dopamine is capable of exerting both stimulatory and 
inhibitory effects depending upon receptor subtype involvement. 
Dopamine exerts its effects through activation of dopamine receptors. The 
physiological action of dopamine is mediated by two distinct families of receptors: 
D1 and D2 dopamine receptors. The classification of dopamine receptors into two 
types was suggested in 1976. This classification was based on anatomical, 
electrophysiological, and pharmacological data. The principal criterion for 
distinguishing the different receptor types is the postsynaptic effectors. Two 
major classes of dopamine receptors have been distinguished according to their 
pharmacological properties and their association with G protein and adenylate 
cyclase. Whereas D1 receptors are positively linked to adenylate cyclase, D2 
receptors are negatively coupled to this enzyme activity [4, 16, 23, 53, 63, 64, 81, 
83].  To date, five dopamine receptor subtypes were identified and characterized 
(Table 1). 
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 Table1. Dopamine Receptor Family [16, 34, 50, 58, 63, 83, 89, 104]. 
 
Receptor  
Family 
 
Receptor 
 
Description 
 
 
D1
Dopamine stimulatory effect 
Predominant Expression: Basal ganglia 
Stimulatory Adenylate cyclase association. 
Predominant postsynaptic location. 
 
 
 
 
 
D1- like 
    
 
D5
Dopamine stimulatory effect 
Predominant Expression: Hypothalamus, corticles. 
Stimulatory Adenylate cyclase association. 
Predominant postsynaptic location. 
 
 
 
D2
Dopamine inhibitory effect 
Dopamine Autoreceptor 
Has two isoforms D2L and D2S. 
Both presynaptic and postsynaptic location.  
Presynaptic function is characterized the best. 
 
 
D3
Dopamine inhibitory effect   
Postsynaptic inhibitory dopamine regulation, 
Potential autoreceptor. 
 
 
 
 
 
 
 
D2 -like 
  
 
D4
Most distantly related to D2-like receptors.  
Functional significance has not been identified yet.
   
 
 
   3 
 Dopamine receptors are located both presynaptically and postsynaptically.  
Dopamine presynaptic receptors are involved in the release and reuptake of 
dopamine. Generally, they are considered a bridge that links presynaptic signal 
with postsynaptic response and play a pivotal role in the determination of  
properties in the responses.  
More than one subtype of dopamine receptor can be expressed 
constitutively in the same cell [48, 50, 58, 105]. The binding of dopamine to 
dopamine receptors mediates receptor activity; in turn, dopamine receptor 
activity is coupled to the multiple second messengers providing mechanisms to 
mediate the control of neurological response by dopamine receptors.  
The best-described effects mediated by dopamine receptors are the activation or 
inhibition of the cAMP pathway, modulation of Ca2+ and K+ channels, and 
potentiation of Arachidonic Acid synthesis.  
 
 
D1 –Receptor Family 
 
 
The primary characteristic of D1-like receptors is the stimulation of Adenyl 
Cyclase (AC).   Dopaminergic receptors of D1 –type are coupled to G-proteins 
and involved in the excitatory influence of endogenous dopamine on activity of 
target neurons in the striatal complex. Experimental data demonstrated that 
excitatory response as activation of D1-receptors mediated by dopamine started 
200 msec after dopamine release and lasted for up to 1 sec.   A tonic stimulation 
of both D1R and D3R receptors by extracellular dopamine was demonstrated, i.e. 
   4 
 the activation of D1 –receptors is correlated with the amplitude of extracellular 
dopamine concentration.  Thus, a full response of D1 –receptors is stimulated by 
both a sufficient duration, up to 300 msec, and high (0.2-1.0µM ) extracellular 
dopamine concentration [33]. Generally, D3R receptors have higher sensitivity to 
dopamine compared with D1R. This may be explained by the fact that both 
receptor subtypes are simultaneously operating, in spite of the much greater 
abundance of D1R over D3R.  [74]. Recently, D3R was also identified as a 
potential candidate to dopamine autoreceptor, but this was debated in different 
experimental studies [46, 105].  
Overall, the experimental data has shown that systematic stimulation of 
D1-like receptors by antagonists increased dopamine efflux. The presence of D1 
– like receptor agonists decreased dopamine release.  However, this finding is 
still controversial;  for example, multiple independent studies of SKF 38393, 
selective D1-agonist, generally demonstrated that this agonist failed to depress 
the release of dopamine. The selective D1 -antagonist, bulbocapnine, failed to 
increase dopamine concentration and counteract the inhibitory effect of 
apomorphine [91].  The experimental data suggests that majority of D1 –like 
receptors are localized postsynaptically [10, 77].    
   5 
 D2-Receptor Family 
 
It is well established that dopamine autoreceptors belong to D2-like 
receptor family [16, 27, 69, 76, 79, 80, 89, 92, 100].  It is believed that 
autoreceptors are responsible for presynaptic dopamine autoinhibition. 
Autoinhibition is a type of presynaptic inhibition in which neurotransmitters 
modulate their own release through presynaptic autoreceptors. The definition of 
presynaptic receptors signifies receptors at axon terminals through which a 
neuron’s own transmitter can, and under appropriate conditions does, influence 
axon terminal function.  The basic evidence for a presynaptic, release-modulating 
autoreceptor consists of the experimental observations that agonists related to 
the transmitter depress transmitter release, while antagonists exert the opposite 
effect.  Presynaptic inhibition is mainly attributable to the activation of G-protein-
coupled receptors, which reduces the presynaptic entry of calcium, a flux 
necessary for transmitter release [5].    
The role of autoreceptors is critical because their activity indirectly 
regulates the function of all other dopamine receptors by modulating dopamine 
concentration.  Once activated by extracellular dopamine, autoreceptors inhibit 
the firing of dopamine neurons, as well as dopamine synthesis and release from 
the neuron. In other words, dopamine autoreceptors expressed by dopamine 
neurons provide negative feedback regulatory control responsible for dopamine 
system homeostasis [4, 5, 63, 69, 76, 80, 92, 106]. For example, with morphine 
and cocaine administration to dopamine D2 receptor mutant (D2R -/-), a direct 
and firm extracellular dopamine concentration increase was demonstrated. 
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 These results were obtained using both complimentary micodialysis and 
voltammetry analyses and showed that the autoreceptor function regulating 
dopamine release is totally abolished in the absence of D2 receptors, despite 
unchanged dopamine uptake and basal dopamine efflux. Also, the experimental 
microdialysis and voltammetry work showed that the deletion of the dopamine D2 
receptors is a sufficient condition to suppress autoreceptor-mediated inhibition of 
dopamine release in rat striatum.  
The experimental work with D2-like specific receptor antagonist 
(haloperidol) and agonist (quinpirole) provided additional information about the 
role played by D2 –like receptors in mediating autoreceptor functions. In vivo 
micodialysis studies of wild type mice showed that haloperidol significantly 
increased the extracellular dopamine level, whereas quinpirole, dopamine 
agonist, significantly decreased the extracellular dopamine level.  The decrease 
in extracellular dopamine concentration is accomplished by reduction in neuron 
firing rates, dopamine synthesis, and dopamine release. In D2R -/- mice neither 
haloperidol nor quinpirole exerted the significant effect on dopamine  
concentration. Importantly, it was observed that D2 –like receptors mediate the 
autoinhibition in condition of high extracellular dopamine concentration [76, 103].  
The fast-scan cyclic voltammetry studies of dopamine receptor effects on 
external dopamine concentration in rat striatal slices also demonstrated the 
decrease in external dopamine concentration  in the presence of D2 agonists 
(quinpirole) and increase in external dopamine concentration in the presence of  
antagonist (sulpiride). In the presence of 1µM of quinpriole, the external 
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 dopamine concentration was 27% - 47% from basal dopamine concentration; in 
the presence of 2µM of sulpiride, the external dopamine concentration was up to 
318% from basal dopamine concentration [45]. It is important to notice, however, 
that the experimental results indicated that the autoinhibition effect was not 
observed at the basal extracellular dopamine level. The maximum autoinhibition 
effect mediated by D2-like receptor was in the range of 10-fold from the basal, 
nM, extracellular dopamine concentration. The basal level of dopamine in D2R -/- 
mice was not affected comparing with Wild Type mice [76].  
The majority of the experimental observations suggested that presynaptic  
autoinhibition prevents excessive dopamine release in pathological conditions. 
The role of autoinhibition in physiological conditions contributes to the attenuation 
of extracellular dopamine during bursts [5].  Overall, despite the quantitative 
differences between endogenous dopamine release in response to a variety of 
stimuli, their regulation by D2-receptors shows very similar characteristics.  
 
 
1.1.2 Dopamine Agonists and Antagonists 
 
Dopamine receptor studies and their pharmacological characterization are 
conducted in the presence of dopamine agonist and antagonist.  Agonists are 
substances that interact with a receptor and elicit an observable response.  The 
process of inhibition or prevention of agonist-induced response is called 
antagonism, and the chemicals entities with such properties are antagonists. 
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 Antagonists are substances that interact with a receptor. Therefore, antagonists 
reduce receptor occupancy by agonists, but antagonists have no biological 
activity. Antagonists are classified as competitive and non-competitive. 
Competitive antagonists have the same recognition site as agonists; non-
competitive antagonists changes recognition site so agonist cannot bind to it. 
Competitive antagonism is most described with mathematical formulas [44, 49, 
62, 66]. 
It is important to distinguish between mixed dopamine receptor agonists 
and antagonists, and specific dopamine receptor agonists and antagonists. 
Mixed dopamine agonists/antagonists do not differentiate between D1 and D2 
receptors, while the specific dopamine agonist/antagonist target D1 or D2 
receptors. The application of mixed dopamine pharmacological agents might lead 
to controversial results, because they act on two receptor families with opposite 
mode of actions in most cases. For example, the quantitative study of dopamine 
in rat striatum demonstrated that at low concentration (2.4nM) of apomorphine, 
mixed dopamine agonist, 78.4% decrease in basal dopamine  concentration was 
observed. When concentration of apomorphine injection was increased to 24 nM, 
only 56.0% decrease in basal dopamine  concentration was observed [26].  Low 
doses of apomorphine, a mixed D1 /D2 receptor agonist, resulted in an inhibition 
of spontaneous locomotor activity associated with extracellular dopamine 
concentration, whereas an increase of the dose led to an increase of locomotor 
behavior above basal level [23].  
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 The experimental studies of dopamine agonists and antagonists 
demonstrated that the effect of dopamine agonists and antagonists on dopamine 
release greatly depends on the firing pattern of the neurons. Burst of high 
frequency would favor the facilitatory actions of antagonists, whereas dopamine 
agonists would exert maximal dopamine release inhibitory effect at lower firing 
rates. The potency of apomorphine on presynaptic receptors, varies greatly with 
duration and rate of stimulation applied.  The inhibitory effect of apomorphine on 
dopamine release was reduced by stimulation with a higher number of pulses 
[19].  The summary of properties for some common dopamine agonists and 
antagonists used in experimental studies is provided in Table 2.     
   10 
 Table 2.   Characteristics of Dopamine Receptor Agonist and Antagonists 
[9, 10, 16, 26, 48, 79, 82, 92].  
 
Ligand Name Characteristics 
  
 
 
Apomorphine
Non-specific dopamine receptor agonist. 
Dopamine release inhibition is observed at 0.01-
1 µM concentration of apomorphine.   
Kd=1.3-8.5nM  
Quinpirole D2-like receptor agonist .Dopamine release 
inhibition is observed at 0.05-1.0 µM 
concentration of quinpirole, inhibition by 70%. 
Kd=4.8 -11.0nM 
 
 
 
 
 
 
 
 
 
 
 
 
Agonists Dopamine Non-specific Dopamine receptor agonist.  
Dopamine release inhibition is observed at 0.01-
1 µM concentration of dopamine.  
Kd= 8.5 - 25.0 nM    (D2-like receptors) 
Kd=2.5 - 25.0 nM (D1 –like receptors) 
Haloperidol D2-specific Dopamine release enhancing is 
observed at 0.01-0.1 µM concentration of 
haloperidol. Kd=1.3-8.5nM 
Sulpiride D2-specific. Dopamine release enhancing is 
observed at 0.01-10.0 µM concentration of 
sulpiride. Kd=3.0-10.3nM 
 
 
 
 
Antagonists 
SCH 233390 D1-specific. Dopamine release enhancing is 
observed at 10.0 µM concentration of SCH 
233390. Kd=19.0-39.8nM 
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 1.1.3 Dopamine Receptor Second Messengers 
 
Adenylate Cyclase   
 
One of the most investigated mechanism linking dopamine receptor 
stimulation with biochemical signals is the differentiation of adenylate cyclase 
activity. D1-like receptors are positive regulators of cyclic AMP    [34, 58, 77, 89 ]. 
Both D1 and D5 receptor activation enhance cAMP formation. Dopamine  and 
other agonists have a higher affinity and potency at the D5 receptor, and systems 
expressing D5 receptors have higher basal adenylate cyclase activity compared 
to D1 receptors.  The inhibition of Adenylate Cyclase activity is a general property 
of D2-like receptors, i.e. D2-like receptors are negative regulators of cyclic AMP. 
Within the D2-like receptor subfamily, both D2S and D2L inhibit cAMP formation in 
all cell lines tested, whereas the D3 and D4 receptors do so in only a few cell lines 
and the inhibition is not that large.  
 
 
Ca2+ and K+ channels 
 
  The progress in techniques for measuring presynaptic Ca2+  influx 
revealed that presynaptic inhibition of elicited neurotransmitter release is largely 
due to the inhibition of presynaptic voltage-dependent Ca2+ channels at the 
synapses [112]. The D1 –like receptors modulate intracellular calcium levels by a 
variety of mechanisms. One of the mechanisms is via the stimulation of 
phospatidylinositol (PI) hydrolysis by phospholipase C (PLC), resulting in the 
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 production of inositol 1,4,5-tripohosphate, which mobilizes intracellular calcium 
stores. Experimental data demonstrates that D2-like receptors could be involved 
in generation of both increase and decrease of intracellular calcium 
concentration.  The role of dopamine receptors has been shown to influence the 
activity of potassium channels. However, this role was primarily documented for 
D2-like receptors. D2 -like receptor activity increases the outward potassium 
current, leading to the cell hyperpolarization. Dopamine  receptor influence on 
potassium current is mediated through interaction with different G-proteins [50, 
58, 105].  
 
 
Arachidonic Acid 
 
Arachidonic Acid (AA) and its metabolites, once released in free form from 
cell membranes, exert a series of physiological actions in many tissues including 
the brain. In primary cultures of neuronal cells, several neurotransmitters, 
including serotonin, norepinephrine, and glutamate stimulate the release of AA. 
The majority of experimental studies supported that D2-receptors modulate the 
synthesis of AA. There is little or no evidence of D1-receptor stimulated synthesis 
of AA [58, 78, 105]. In contrast, D1-like agonists caused an inhibition of AA 
release. The inhibition of AA release exerted by D1-dopamine receptor 
stimulation appears to be mediated by cAMP. Interestingly, that simultaneous 
expression of D1 and D2 receptors in the presence of both D1 and D2 agonists 
caused a greater potentiation of AA release than D2 agonist alone.  
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 1.1.4 Extracellular Dopamine Concentration 
 
 
Micodialysis and fast-scan cyclic voltammetry are two principal 
experimental techniques used to investigate extracellular dopamine  
concentration.  In vivo microdialysis is a powerful neurochemical technique for 
sampling the extracellular space of the brain in order to gain information about 
the chemical environment around neurons. Microdialysis is a useful analytical 
tool for sampling of the interstitial concentration of endogenous substances in the 
extracellular space of various tissues. The quantitative microdialysis techniques 
have been used as methods to obtain more precise information about the 
dynamics and actual extracellular concentrations of neurotransmitters [8, 12, 14, 
32, 52, 53, 102].  Most neurotransmitters under physiological conditions are 
known to have a basal extracellular space concentration.  
The experimental data demonstrates very low 10-9  Mole (nM) range for 
basal extracellular dopamine concentration. The extracellular concentrations of 
dopamine metabolites DOPAC (3,4-dihydroxyphenylacetic acid) and HVA 
(homovanillic acid) were found to be 150-500 times higher than the extracellular 
dopamine concentration [3, 22, 32].  A lot of experimental studies of dopamine 
neurotransmission have focused on the striatum because of low concentration of 
interfering neurotransmitters. For example, norepinephrine concentration in 
striatum is 3 nM comparing with basal dopamine concentration, which is in the 
range of 7-30nM [3, 14, 22, 26, 29, 32, 42, 92].  
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 In unstimulated brains, a spatially and averaged steady-state 
concentration is sustained by tonic dopamine release. Dopamine release is 
proposed to underlie the background, steady-state level of extracellular 
dopamine. Passive dopamine diffusion from dopaminergic terminals weekly 
contributes to the extracellular dopamine level. Overflow of dopamine is detected 
during a stimulus pulse train, and extracellular dopamine concentration  
diminishes rapidly (within 5 sec) to basal level when the stimulus is terminated 
[14, 111].  
Dopamine release is considered to be a discrete process described by 
rate of dopamine release. The physiological level of dopamine release is 5-10 
pulses/sec.  At a release rate 30 pulses/sec, dopamine concentration increases 
to a detectable level. At a release rate 60 pulses/sec, dopamine extracellular 
concentration increased up to 10 µM.  Experimental data demonstrated that 
dopamine concentration released into extracellular fluid was 0.049-0.250µM per 
pulse in rat striatum [14, 41, 110, 111].  The rate of dopamine disappearance is 
independent of the dopamine release rate. The maximal experimentally observed 
rate of dopamine disappearance was 5.1 µM/s [32, 111].     
Considerable insight was gained into the factors which regulate 
extracellular concentration of dopamine. Of particular interest is the ways in 
which dopamine concentration can vary in response to administration of 
pharmacological agents. Overall, the presence of dopamine antagonist leads to 
increase in extracellular dopamine concentration, while the presence of 
dopamine agonists decreases extracellular dopamine concentration.  
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 1.1.5  Presynaptic/Postsynaptic Regulation of Extracellular  
Dopamine Concentration by Dopamine Receptors 
 
 
The observations in a great number of experimental studies indicate the 
existence of both presynaptic and postsynaptic regulation of extracellular 
dopamine concentration mediated by dopamine receptors. The presynaptic 
inhibition of  neurotransmitter release was shown by many transmitters at most 
synapses.  For example, the activation of presynaptic receptors, such as 
adenosine A and GABA receptors mediates some forms of synaptic depression 
at neuromuscular junctions. Presynaptic inhibition might serve as a mechanism 
for synaptic depression to prevent excessive transmitter release [112].   
Presynaptic dopamine autoreceptors (D2-like) are known to be activated 
by released dopamine and serve as an important feedback loop. The presynaptic 
inhibition of dopamine release is a physiological mechanism by which 
extracellular dopamine stimulates presynaptic autoreceptors to further inhibit 
dopamine release from neuron.  Experimental evidence suggested that both 
release and uptake, determining extracellular levels of dopamine, are governed 
by presynaptic autoreceptors. Further, it is believed that activity of dopamine 
neurons is regulated by short and long feedback pathways. The short feedback 
pathways, mediated by inhibitory D2 –like autoreceptors. Little is known, 
however, about long feedback pathways. By definition, long feedback pathways 
involve dopamine receptors located on postsynaptic neurons [62, 76, 77, 85, 86, 
112].  
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 D2-like receptors are the principal autoreceptors of presynaptic dopamine 
concentration control.  The existing experimental data suggests  that D2-like 
autoreceptors operate in the high-affinity agonist state, as opposed to dopamine 
postsynaptic receptors that operate in the low-affinity state [63].  
 Dopamine released from a presynaptic side has actions beyond the 
immediate presynaptic receptors.  For example, D2 –like receptors are expressed 
as both presynaptic and postsynaptic receptors:  D2L acts mainly at postsynaptic 
sites and D2S serves presynaptic autoreceptor function.  It has been proposed 
that D2L and D2S receptors have different and probably antagonistic functions in 
vivo. D2S is principally a D2 -like presynaptic autoreceptor, which at the 
postsynaptic level negatively modulates D1-like receptor response. In contrast, 
the D2L receptor mediates the postsynaptic cooperative/synergistic effect with D1-
like receptors [76, 104].   
D3, D1 –like receptors, are potential candidates for  dopamine 
autoreceptors, mediating a postsynaptic inhibitory feedback. It was shown that in 
D3 receptor absence, dopamine efflux would be increased [46, 76].   Overall, it is 
thought that D1 –like and low-affinity D2 –like receptors are principal receptors 
involved into postsynaptic dopamine concentration control.  Postsynaptic control 
is not active under basal extracellular dopamine concentration, but under higher 
dopamine concentration, it contributes to dopamine concentration control. 
Dopamine autoreceptor agonists are able to stimulate supersensitive, but not 
normosensitive, postsynaptic receptors. Both D1 and D2 -receptors must be 
activated simultaneously for postsynaptic behavioral effects.  [4, 63, 70, 77, 92].         
   17 
 1.1.6 D1:D2 Dopamine Receptor Interaction 
 
A remarkable feature of normal dopaminergic transmission is that for 
many dopamine behavioral and pharmacological effects the concomitant 
stimulation of D1 and D2 class receptors is required [18, 28, 37, 74, 85, 86, 102, 
103, 104]. Both opposite and cooperative/synergistic interaction between 
dopamine D1 and D2 –like receptors have been proposed on the basis of the 
pharmacological studies. The theoretical aspects of the functional interactions 
between D1 and D2 receptors suggest four possibilities: antagonism, indifference, 
additive synergy, and potentiation [16, 18].  These interactions may involve 
receptors present on either different cells or a single cell with, in the latter case, 
interaction between the transduction pathways of co-expressed receptor 
subtypes.  For example, the lack of D2L profoundly decreases postsynaptic 
responses to dopaminergic agonists, strongly suggesting that D2L is the 
postsynaptic D2 receptor that works in concert with D1-like receptor. Further, D2S 
inhibits D1 receptor-mediated function which also indicates a circuit of signaling 
interference between dopamine receptors. These qualitative and quantitative 
forms of D1/D2 dopamine receptor synergism are abolished by chronic dopamine 
depletion [37, 104].  
The investigation of the role of action potential in the manifestation of 
D1/D2 synergism demonstrated that synergistic receptor interaction occurs under 
conditions in which action potential is prevented and depends on agonist 
stimulation of D2, but not D3 and D4 receptors [47].  In addition it has been 
   18 
 demonstrated that stimulation mediated by a high dose (10-5 M) of dopamine 
may involve a synergistic interaction of D1-like and D2-like receptors through their 
common physiological ligand, most likely G-proteins [48]. The state of D1/D2 
synergism was found to be independent of striatal D1 and D2 receptor density. 
Importantly, it has been observed that when D1-like receptor mediated process is 
sufficiently activated, D2-like receptor potentiation is nor longer discernible [43]. 
The D1/D2 synergism seems to be postsynaptic receptor interaction. It is 
necessary, however, to have D2 receptor occupation in addition to D1 stimulation 
to achieve full postsynaptic functional effect [63, 106].  The studies of 
endogenous dopamine-mediated feedback suggested that under basal 
conditions spontaneously released dopamine acts primarily through D2-like 
receptors to inhibit dopamine release. However, when dopamine release is 
increased by the presence of dopamine antagonists, a major portion of feedback 
inhibition depends on concurrent activation of D1- and D2-like receptors. Also, it 
was proposed that dopamine receptors on target neurons are responsible for    
D1–D2 interaction in feedback control of dopamine cells instead of dopamine 
autoreceptors.   
The involvement of both D1 and D2 receptors in feedback control of 
dopamine neurons could have significant implication on extracellular dopamine 
concentration in the presence of dopamine receptor ligands. At low doses, D2 
selective agonists may act preferentially on D2 autoreceptors to inhibit the activity 
of dopamine releasing neurons. Thus, at low doses of D2 –selective drugs would 
reduce the release of dopamine. This reduction in extracellular dopamine lessens 
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 the postsynaptic D1 receptor stimulation and prevents D1 receptors enabling the 
postsynaptic effect.  At higher concentrations, dopamine agonists will act on D1 
receptors leading to further inhibition of dopamine release.  
The more complex situation should be observed at the presence of D2 
antagonists which are majority of the antipsychotic drugs. D2 antagonists are 
known to block dopamine release feedback inhibition, leading to the increase of 
extracellular dopamine concentration. The increased availability of extracellular 
dopamine would lead to the activation of D1 receptors mediating dopamine 
feedback inhibition thus casing effect opposite to the action of D2 antagonists  
[63, 70, 77, 85, 86].   
 
 
 
1.1.7 Extracellular Dopamine Level Control by Dopamine Transporter  
 
 
To discontinue neurotransmission, neurotransmitters in synaptic cleft are 
inactivated by three general mechanisms: diffusion out of synapse; degradation 
by specific enzymes; and reuptake back to presynaptic terminal.  
In a dopaminergic system, reuptake seems to be the primary mechanism 
for neurotransmitter inactivation. The extracellular dopamine concentration within 
the striatum depends largely on a balance between vesicular release of 
dopamine and reuptake of the released dopamine through dopamine transporter 
(DAT).  
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 DAT is an integral membrane protein spanning the membrane and is 
exposed on both sides of membrane. DAT plays an important role in terminating 
dopaminergic neurotransmission and in setting overall dopaminergic tone in the 
central nervous system [11, 22, 41, 53, 60, 72, 111, 117 ].  
DAT clears neurotransmitters from the extracellular space and serves as 
an important regulator of signal output and duration at dopaminergic synthesis.        
For example, in mice lacking DAT, there was 5-fold increase in the extracellular 
dopamine as compared to wild-type mice [31].  The real-time characterization of 
dopamine overflow in vivo, showed the decrease of 76% in dopamine  
disappearance rate in the presence of high concentration of DAT inhibitor, 
nomifensine. Nomifensine is dopamine reuptake site blocker and it  was used to 
increase extracellular dopamine concentration in dopamine radioligand binding 
studies [59, 108, 111].  In vivo microdialysis studies of dopamine mass transfer 
and reuptake demonstrated that before dopamine reuptake inhibition, the lifetime 
of dopamine in the extracellular space is shorter than it takes for dopamine to 
diffuse from release site to probe. After reuptake inhibition, the lifetime of 
dopamine in the extracellular space was prolonged sufficiently [116].  It is shown 
that DAT uptake system located predominantly in the presynaptic terminals and it 
is functioning to restrict the distribution of synaptically released dopamine.   
The increase in extracellular dopamine triggers the hypersensitivity 
resulting in increased locomotor activity and euphoria. These conditions, for 
example, were observed in mice that completely lack a functional DAT and have 
persistent high extracellular dopamine concentration. 
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  It is believed that the elevation of striatal basal dopamine concentration 
by cocaine is to the great extend due to DAT inhibition [19].   It  was 
demonstrated that cocaine is a competitive inhibitor of dopamine uptake by DAT. 
The experimental studies showed that KM for dopamine uptake was increasing 
from 1.06 µM to 3.90 µM when cocaine concentration was increased from 0.0 µM 
to 2.0 µM, while Vmax was not changed [11].  Amphetamine, a central nervous 
system stimulant, increases extracellular dopamine levels by reversing the 
dopamine uptake transporter, causing dopamine release instead of reuptake 
[38].  Kinetic parameters for dopamine uptake by DAT in rat striatum are shown 
to be as follows Vmax is in the range of 1.56-5.0µM/s; Km is 0.2 µM [39, 110, 111]. 
Vmax is maximum velocity of dopamine uptake by DAT. Km   is dopamine 
concentration at which dopamine reuptake velocity is half of Vmax.    
The growing amount of experimental results demonstrate the involvement 
of D2 autoreceptors into the regulation of DAT. Studies with mice in which the 
dopamine D2 receptor has been knocked out demonstrated the slower dopamine 
clearance than in wild type mice.  The study of D2 receptor- deficient mice 
showed that presynaptic D2 autoreceptors regulate DAT activity. For example, 
the clearance of locally applied dopamine was decreased by 50% in D2 (-/-)  mice 
relatively to that in D2 (+/+) mice [22].  
Possible mechanism for DAT modulation by D2 comes from the reports 
that DAT is voltage-dependent. The activation of D2 dopamine receptors opens 
K+ channels, resulting in transient hyperpolarization of the membrane.  
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 It is thought, that this hyperpolarization could, in turn, increase DAT velocity and 
dopamine uptake [54].  
Overall effect of dopamine agonists and antagonists on dopamine uptake 
was evaluated and it was shown that quinpirole, a dopamine D2 receptor agonist, 
increased dopamine uptake and blockage of this effect by the addition of 
sulpiride, D2 antagonist. Haloperidol, D2 antagonist, inhibits dopamine uptake by 
DAT. The dopamine half-life was measured to be 73 msec before haloperidol 
and 104 msec after haloperidol addition [5].  
    
 
 
 
 
1.1.8 High- and Low- Affinity States of D1 and D2 Dopamine Receptors 
 
 
 
It was reported that both D1 and D2 receptors exist in two states. One state 
has a high affinity for dopamine, while the other state has a low affinity for 
dopamine. For the low-affinity state, the binding constants for D1 and D2 
receptors are at the µM level, while their high-affinity state has binding constants 
at nM ranges. The high affinity state is sensitive to dopamine concentrations in 
the basal, 1-50 nM range. The experimental data for dopamine equilibrium 
dissociation constants in rat striatum were reported in 0.8- 50 nM range for High 
Affinity dopamine receptors and in 228-17,000 nM for Low Affinity dopamine 
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 receptors. Thus, dopamine receptors exist in various adaptational states which 
can influence drug actions. It is believed that about 20% of D1 receptors are in 
high-affinity state under the physiological conditions [1, 14, 38, 63, 81, 84, 94 ].    
 
 
 
1.1.9  Feedback Control is Important Process to Controlling Extracellular              
Dopamine Concentration 
 
While a drug, or other foreign molecule, will generally be eliminated from an 
organism, the concentration of an endogenous ligand will remain within limits 
around a basal state. This control has been documented for many 
neurotransmitter systems. Central neurotransmitters are homeostatically 
maintained through release, elimination and feedback control mechanisms.  
The flow of information from the system “output” to the “input” that 
regulates the input to maintain stable set point is commonly described as a 
feedback mechanism. Homeostatic regulation is regulation that maintains the 
level of variable at or near a fixed value. Regulation not only maintains a variable 
at fixed level, but also adjusts the variable to that level, even if the initial value is 
quite different. Homeostasis is a stable set point to which the system tries to 
return itself under normal conditions. This set of normal, steady-state values, can 
be regarded as the operating point of the system [25, 57, 75, 90, 96, 115].  
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 The system is often characterized by its ability to minimize changes in 
response to the external disturbance, i.e. system has an ability to stabilize. This 
is also viewed as a homeostatic ability of a system.   
Dopamine receptor-mediated feedback control plays a significant role in 
dopamine neurotransmission. Autoreceptors provide important feedback control 
during dopamine signaling by governing firing rate, synthesis, and release.  
The feedback control mechanism is not unique for dopamine receptors, the 
experimental data supporting the existence of feedback control was obtained for 
cholinergic, noradrenergic, and ABA-ergic axon terminals [25, 92]. 
 The experimental data suggested that dopamine receptors mediate 
negative feedback to provide extracellular dopamine concentration control. 
The negative feedback regulation is often referred to as deviation-counteracting, 
i.e. it causes the influence of a disturbance to be minimized so that the system 
maintains, within limits, a constant output. Traditionally, physiological control 
systems have been viewed as governed by homeostasis. Generally, negative 
feedback loops result in homeostasis.  
Dopamine D2 receptors agonists reduce firing rate, synthesis, and release 
of dopamine in dopaminergic neurons by means of a negative feedback 
mechanism via stimulation of autoreceptors.  In the presence of antagonists, 
dopamine release is increased. This suggests that the negative feedback loop  
acts physiologically to prevent excessive release of neurotransmitter.  
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 1.2  EXTRACELLULAR DOPAMINE CONCENTRATION MODELING 
 
 
1.2.1   Physiological Model for Extracellular Dopamine Concentration 
Control 
 
 
The dopaminergic neurotransmission is a complex and tightly controlled 
process that involves synthesis, release, uptake, receptor binding, subsequent 
activation of signal transduction systems, and termination of the neurotransmitter 
action. Extracellular level of dopamine within striatum is thought to depend 
largely on a balance between vesicular release of dopamine and reuptake of the 
released dopamine through DAT.   
The important role of DAT and the existence of two distinct families of 
receptors with different biochemical and pharmacological properties suggested 
considering a physiological model of dopamine concentration control mediated 
by a system with both DAT and D1/D2 receptors. The physiological model of 
extracellular dopamine concentration control was proposed on the basis of the 
extensive literature review for the dopaminergic system. In this model, dopamine 
concentration is controlled by DAT uptake; presynaptic  D2-like autoreceptors;  
and postsynaptic D1 – like receptors (Figure 1). 
1
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DAec - extracellular dopamine; 
DAT - dopamine transporter; 
D1 -    D1 -like receptors; 
D2 - D2 -like receptors. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.  Physiological Model for Extracellular Dopamine Concentration 
Control: Control of extracellular dopamine concentration is mediated 
presynaptically and postsynaptically. D2-like autoreceptors and DAT 
are mediating presynaptic control. D1- like receptors are mediating 
postsynaptic control.    
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 The signal transduction is generated by second messengers as a result of 
dopamine interaction with dopamine receptors. Overall, the experimental 
literature data review suggests that under a moderate dopaminergic tone,  
extracellular dopamine concentration is mainly regulated by the inhibitory D2 
presynaptic autoreceptors. Under the circumstances of increased dopaminergic 
activity, recruitment of postsynaptic stimulatory D1 receptors is required.  
 
 
 
1.2.2  Overview of Existing Computational Models for  
Extracellular Dopamine Concentration Control- Kinetic Approach 
 
 
 
The majority of scientific discoveries and explanations of biochemical 
mechanisms in physiological systems arise from an extensive amount of 
experimental work. However, the computational modeling of complicated 
biological processes represents an effective approach in predicting and 
quantifying the tendency in the physiological system. The mathematical modeling 
of the physiological systems has been proven to be a powerful tool to explore 
and predict the behavior of natural systems [15, 25, 57, 113 ].  
Models can never provide an absolute decision about a biological 
hypothesis, but they are very useful methods to obtain a deeper understanding of 
the experimental system. Models can be used to determine limits, capabilities, 
and weakness of the systems. They can also define how to optimize a complex 
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 system. The computational modeling is being used in application to different 
fields of biomedical research such as modeling of Oxygen Concentration in 
tissues, Drug Receptor Interaction, Signal Transduction.  
Several approaches to computational modeling of extracellular dopamine 
concentration control were found in the literature.  For example, the dynamics of  
extracellular dopamine level were modeled with an equation with two 
components: dopamine release and dopamine uptake [by Wightman et al 1988, 
111 ].  
 
uptake
EC
release
ECEC
dt
DAd
dt
DAd
dt
DAd }][{}][{][ −=   (1) 
 
where [DA]EC – is extracellular dopamine concentration 
 
 
 
 
Equation 1 describes the kinetic model for the extracellular dopamine 
concentration control. In Equation1, the release of dopamine is a discrete 
process, a function of the dopamine release rate from the neuron, i.e. a function 
of the number of dopamine release pulses during the time t (pulse/s).  The 
uptake of dopamine by the transporter is a continuous process obeying 
Michaelis-Menten kinetics. Thus, the concentration of extracellular dopamine at 
any point can be described according to Equation 2 [110, 113]. 
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where [DA]p, j   – is dopamine concentration release per  pulse;  
Vmax    – is a maximum velocity of DA binding to DAT;  
   Km       –  is an extracellular dopamine concentration when 
the velocity of dopamine uptake is a half from the 
maximum velocity. 
 
Although this model worked relatively well to predict Km and Vmax values 
for extracellular dopamine, it did not, however, explain the unusual dynamic of 
extracellular dopamine suggesting that more complex models are required to 
describe the features of dopamine concentration control [113].    
Considerably more comprehensive models of the dopaminergic nerve 
terminal have been developed by including processes of dopamine synthesis, 
transfer of dopamine between a releasable and an inactive pool, and metabolism 
of dopamine by monoamine oxidase [41].  Michaelis-Menten kinetics were also 
used for the modeling interaction between diffusion and dopamine uptake in 
striatum.  In this modeling both linear and non-linear equations describing 
dopamine uptake were considered. Non-linear extracellular dopamine 
concentration modeling is especially critical in the situation of neurotransmitter 
overflow, which can be achieved by either electrical stimulation or application of 
dopamine uptake inhibitors. The development of this model, however, excluded 
important receptor-mediated regulation of extracellular dopamine concentration 
control process.   
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 Kinetic models theoretically might lead to dopamine concentration 
decrease below pre-stimulation baseline. However, no existing data supply 
evidence of dopamine concentration below baseline, indicating the essential role 
of feedback process maintaining dopamine concentration within certain level [12, 
14, 41].    
 
 
 
1.2.3  Overview of Existing Extracellular Dopamine Concentration Control 
Model- Law of Mass Action and Negative Feedback Approach 
 
 
 The interaction of dopamine with dopamine receptors can be modeled as 
ligand receptor interaction according to the law of mass action [44, 95, 96, 97, 
115]. The interaction between ligand (L) and the specific receptor (R) is modeled 
as a reversible biomolecular reaction leading to the formation of a ligand-receptor 
complex. The law of mass action states that the rate of a reaction is proportional 
to the product of the concentration of the reactants: 
 
   k1 
L + R       LR     (3) 
  k2  
 
where   k1 – rate of forward reaction, ligand binding to receptor; 
 k2 – rate of backward reaction, ligand dissociation from receptor. 
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 Once binding has occurred, ligand and receptor remain bound together for a 
random amount of time influenced by affinity of the receptor and ligand.   
After dissociation ligand and receptor are the same as they were before binding. 
Equilibrium reached when the rate of LR complex formation is equal to LR 
complex dissociation. The assumptions of receptor ligand interaction modeling 
are that all receptors are equally accessible to ligands; binding is reversible;  
neither ligand nor receptor are altered by binding.   
 The initial theoretical work focused on the study of ligand-receptor 
interaction obeying the mass action in the presence of a negative feedback 
function (Ф) was done back by Tallarida in 1990 [95, 96, 97].  The interaction 
between ligand and receptor is mediating feedback (Ф) which is a function of 
receptor occupancy by ligand. Feedback, in turn, is regulating concentration of 
free ligand (L): 
 
 
  k1 
L + R       LR +   Ф (LR)  (4) 
  k2 
 
 
 
 
In this modeling, the rate of forward reaction depends on forward reaction 
rate (k1), free ligand concentration (z), total available receptor concentration (Rt  -
y). The rate of backward reaction is function of backward reaction rate (k2) and 
concentration of ligand-bound receptors (y). 
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  Equations 5 and 6 describe instantaneous ligand-bound receptor 
concentration and free ligand concentration in the presence of the feedback 
function. 
][]][[ 21 ykyRzkdt
dy
t −−=                (5) 
 
)(][ yFzE
dt
dz Φ++−=       (6) 
 
where  y  – concentration of ligand-bound receptor (receptor occupancy); 
Rt – total receptor concentration; 
z   – free ligand receptor concentration; 
E – free ligand elimination rate constant due to uptake, 
degradation; 
F – ligand generation rate due to release from neuron; 
Ф(y)-feedback function related to the receptor occupancy by ligand. 
 
 
Although, the described model of neurotransmitter concentration provided the 
solid mathematical foundation to predict the change in neurotransmitter 
concentration and its ability to return to the operating point, it did not, however, 
address the physiological complexity of dopamine control described in 
experimental studies, i.e. the existence of multiple receptors with the distinct 
pharmacological properties. Further it did not distinguish between presynaptic 
and postsynaptic control and continuous dopamine uptake by transporter.   
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 1.2.4   Proposed Extracellular Dopamine Concentration Control Model: 
Feedback Model for System with D1 / D2 Receptors and Dopamine 
Transporter. 
 
 
 
Based on the review of published experimental and modeling data for 
extracellular dopamine concentration control, a physiological model integrating 
dopamine release, dopamine uptake, and negative feedback mechanism was 
proposed. According to this proposed model, the released dopamine 
continuously is taken up in a constant rate by the dopamine transporter,  and free 
extracellular dopamine binds to presynaptic autoreceptors (D2 ) and postsynaptic 
receptors (D1) . Depending on the receptor occupancy by dopamine, feedback is 
generated by presynaptic autoreceptors (D2 ) only, or by both presynaptic (D2) 
and postsynaptic (D1) receptors . Postsynaptic dopamine receptors are activated 
when presynaptic dopamine receptors are activated (occupied).  
Dopamine uptake by DAT is assumed to follow Michaelis-Menten kinetics. 
Dopamine binding to dopamine receptors can be expressed according to law of 
mass action. A diagram for proposed model for extracellular dopamine 
concentration control is shown on Figure 2.  
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DAEC- extracellular dopamine;  D1R - D1 -like receptor; 
D2R - D2 -like receptor;    DAT- dopamine transporter. 
    
 
Figure2.  Diagram for Proposed Model of Extracellular Dopamine 
Concentration Control. 
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 The simplifying assumptions for proposed dopamine concentration control model 
are as follows: 
1. The concentration of free dopamine is much greater than bound 
dopamine.  
2. Dopamine is released discretely from the neuron to the extracellular 
space. 
3. The released dopamine concentration is constant per pulse. 
4. The presynaptic control of dopamine concentration is mediated by 
negative feedback generated by DAT and dopamine autoreceptors (D2).   
5. Dopamine uptake by DAT is a constant rate continuous process. 
6. There is no interaction between presynaptic D2-like receptors and 
dopamine transporter mediating an additional  dopamine extracellular 
concentration control. 
7. There is no dissociation of dopamine from transporter back to synaptic 
cleft. 
8. The feedback generated by dopamine receptors is a function of receptor 
occupancy by dopamine.  
9. Dopamine receptor density is constant. 
10. Postsynaptic control of extracellular dopamine concentration is mediated 
by D1 receptor negative feedback.  
11. Postsynaptic receptors (D1) are activated only when presynaptic 
autoreceptors (D2) are activated (occupied).  
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 12. There is no interaction between D1/D2 receptors mediating an additional   
dopamine extracellular concentration control. 
 
Computational approach for the proposed model for extracellular 
dopamine concentration control, relies on the general negative feedback 
equation. Let’s first describe the general feedback diagram and equation prior to 
introducing equations for the proposed model for extracellular dopamine 
concentration control. A diagram for the system with negative feedback is shown 
on Figure 3. 
 
 
 
      E 
   C R  ε 
  
 G 
 
 Ф 
 
 
 
 
 
 
Figure 3.  General Diagram for Feedback Control System [20, 55, 71]. 
  R - Input Signal; 
  ε -Error Signal; 
  G -Transfer Function; 
  C -Output Signal from the System; 
  Ф -Feedback Function; 
  E -Output Signal from Feedback Function 
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 Equation 13 is the general equation for the negative feedback system.  
Equations 7-12 demonstrate how Equation13 was derived. 
   
GC ⋅= ε       (7) 
 
Φ⋅= CE    (8) 
 
ER −=ε    (9) 
 
GERC ⋅−= )(   (10) 
 
GCRC ⋅Φ−= )(   (11) 
 
GCRGC Φ−=   (12) 
 
G
RGC Φ+= 1    (13) 
 
 
 
The model for the extracellular dopamine concentration control can be also 
represented as diagram for the system with negative feedback (Figure 4).   
   
    
  
 
   38 
  
 
 
 
 
 
 
 
 
 
 
Ф (Receptors) 
C (DAEC) 
G (DAT) 
R (DAinput) 
 
 
Figure 4.  Proposed Negative Feedback Control Model for Extracellular 
Dopamine Concentration Control. 
 
  R (DAinput)  - Dopamine Release; 
  G (DAT)  - DAT Transfer Function (Uptake); 
  C (DAEC)  - Extracellular Dopamine Concentration ; 
   Ф (Receptors)  - Feedback Function mediated by dopamine 
          receptors.  
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 Thus, negative feedback  model for extracellular dopamine concentration control  
system can be presented by Equation 14: 
 
DATceptors
DATinput
ec G
GDA
DA
Re1 Φ+
=    (14) 
 
Equation 14 provides the mathematical model for extracellular dopamine 
concentration control governed by dopamine release (DAInput ), dopamine uptake 
(GDAT ), and feedback control (ФReceptors ).  Where DAinput   is a function of 
dopamine release concentration per pulse and neuron firing rate; GDAT is obeying 
Michaelis-Menten kinetic (Vmax, Km ) ; ФReceptors is a function of receptor (D2 /D1) 
occupancy by dopamine.   
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2.  METHODS 
 
2.1 MODEL VARIABLES and MODEL EVALUATION CONDITIONS 
 
 Dopamine system modeling was based on data from published 
experimental data for rat striatum dopamine system and the program generated 
computational data (Table 3).  
 
 
Table 3. Data Sources for Dopamine Concentration Control System 
Modeling.   
 
Model 
Functions 
 
Independent Variables 
 
Data Source 
 
 
Input Dopamine 
Concentration 
Dopamine Release Rate;  
Dopamine concentration released per 
pulse  
 
 Literature 
  
 
Dopamine 
uptake by DAT  
 
Maximum velocity of DA binding to DAT 
(Vmax) ; 
Extracellular dopamine concentration  
when the velocity of dopamine uptake is a 
half from the maximum velocity ( Km) 
 
Literature and 
Computational  
 
 
Negative 
Feedback by 
Receptors  
 
D2 Occupancy; 
D1 Occupancy 
 
Computational 
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The development of any computational model starts with the 
determination of independent and dependent variables for a model.  
 Independent variables are fixed system parameters and/or changing input 
variables.  Table 4 summarizes dopamine model system independent variables.  
The extracellular dopamine concentration is dependent variable for the model.  
 
Table 4. Independent Variables for Dopamine Concentration Control Model. 
Independent Variable 
Name 
 
Value  
 
Units 
 
References 
 
Dopamine Release Rate  
 
7-120 
 
Pulse/s 
 
14, 41,110,111 
Dopamine Concentration 
released per pulse, [DA]P
 
0.049 
 
µM 
 
14, 41,110,111 
Michaelis-Menten Constant 
for DAT, MDAT
 
0.2 
 
µM 
 
110, 113 
Maximum Velocity for DAT 
Uptake, Vmax
 
5.0 
 
µM/s 
 
110, 113 
Basal Extracellular 
Dopamine Concentration, 
DABasal
 
0.022 
 
µM 
 
3,14, 22, 26, 
29, 32, 42, 92 
 
The presented computational modeling was used to evaluate the 
contribution of DAT and feedback mechanisms to maintain basal dopamine 
concentration; test the extracellular dopamine concentration outcomes under the 
conditions of increased/decreased dopamine release; and predict the changes in 
extracellular dopamine concentration under conditions equivalent to the presence 
of dopamine agonist/antagonists in the experimental dopamine system.  
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Overall, there were three series of model simulations conducted:  
1. Extracellular dopamine concentration control by DAT uptake only;  
2. Extracellular dopamine concentration control by DAT uptake and 
Negative Feedback mediated by Receptors (D2 or D2 /D1). The 
extracellular dopamine concentration was estimated for the 
conditions of different dopamine release rates.  
3. Extracellular dopamine concentration change under the conditions 
equivalent to an agonist/antagonist presence.  Extracellular 
dopamine concentration is controlled by DAT uptake and Negative 
feedback. 
The first series of the computer simulations were used to generate computational 
data for the extracellular dopamine concentration control by DAT uptake. This 
data was used to model GDAT function. The second series of the computer 
simulations were used to generate computational data for the extracellular 
dopamine concentration control by DAT uptake and Receptor Negative 
Feedback. This data was used to model Ф Receptor function.  The third series of the 
computer simulations were used to generate computational data for prediction of  
the extracellular dopamine concentration under conditions equivalent to the 
agonist/antagonist presence in dopamine system . This data was used to 
evaluate the model performance, i.e. this computational data was compared with 
the published experimental data.  Table 5 outlines the computational steps for 
the extracellular dopamine concentration control model development and 
evaluation.      
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Table 5.  Dopamine concentration control model: development and 
evaluation computational steps.  
 
Modeling Conditions 
 
Computational  Steps 
 
  Uptake
 
Negative 
Feedback
Agonist/ 
Antagonist 
Presence 
 
Output 
Modeling 
Function 
 
To evaluate the contribution of 
DAT to control extracellular 
dopamine concentration 
 
Yes 
 
No 
 
No  
 
GDAT
 
To analyze the contribution of 
DAT and Feedback to control 
extracellular dopamine 
concentration   
 
Yes 
 
Yes 
 
No 
 
ФReceptors
 
To predict  change in 
extracellular dopamine 
concentration in the presence of 
dopamine agonists/antagonists 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
DAEc 
Change 
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2.2 COMPUTATIONAL TOOLS 
 
SAS (Version 8.2, SAS Institute Inc.) was used to write computational 
program to model the extracellular dopamine concentration.  
The fourth order Runge-Kutta method was used as a numerical method  
for differential equation solution: uptake by DAT (Equation 2) and receptor 
occupancy (Equation 5): 
 
∑ ∫
= +−=
n
j
t
m
jpEC DAK
dtV
DAtDA
1 0
max
, 1]/[
][)(][   (2) 
 
][]][[ 21 ykyRzkdt
dy
t −−=   (5) 
 
The fourth order Runge-Kutta method is generally considered to provide an 
excellent balance of power, precision, and relative simplicity to program. An 
approach to developing an algorithm for integrating a differential equation is to 
write down the formal integral of the equation and then to approximate the 
integral [2]. 
∫=⇒= t dtytftyytfdtdy 0 ),()(),(  
∫ ∫∫ + ++=+=⇒ + 1 1 ),(),(),(01 nn nnn
t
t
t
tn
t
n dtytfydtytfdtytfy  
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The algorithm effectively uses the derivative of the function evaluated at the 
midpoint to predict the solution at the end of subinterval. The fourth order Runge-
Kutta method is described with the following set of formulas: 
6
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To assure the accuracy of Runge-Kutta algorithm calculations in program, 
the developed SAS program for Runge-Kutta method was tested for several 
problems in Math textbook [24]. The Runge-Kutta algorithm solutions were tested 
for the following linear, non-linear, and exponential differential equations: 
xy
dx
dy +=    xey
dx
dy −−= 65  
22 xy
dx
dy +=    )10100(00016.08.9 32 vvv
dv
dy ++−=  
All solutions generated by SAS algorithm were consistent with data in Math 
textbook.  Runge-Kutta SAS algorithm and solutions generated by SAS program 
for above differential equations are provided in (Appendix 1).  
Further, SAS developed program for DAT uptake based on literature 
proposed kinetic model (Equation 2) was tested under conditions specified in 
literature [111].  The results generated by computational SAS program were 
consistent with the published computational data (Appendix 2).   
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2.3 COMPUTATIONAL METHODS 
 
2.3.1 Computational Evaluation of Extracellular Dopamine Concentration   
  Control by DAT Uptake. GDAT Modeling  
 
 To simulate the extracellular dopamine concentration in rat striatum, the 
dopamine concentration control model was developed and tested using literature 
experimental parameters for DAT uptake. The extracellular dopamine 
concentration was estimated for dopamine release firing rates in the range from 6 
to 120 pulse/s and 5 sec stimulation duration. The extracellular dopamine 
concentration profile was shown for 5 sec.  
The modeling formula for the extracellular dopamine concentration when 
control is under DAT uptake, i.e. feedback is absent,  is derived from the general 
formula for proposed dopamine concentration model as follows: 
 
DATInput
DAT
DATinput
ec GDAG
GDA
DA =⋅+= 01   (15) 
 
GDAT  can be calculated according to Equation 16: 
 
Input
ec
DAT DA
DA
G =      (16) 
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In Equation 16, DAec can be calculated according to Equation 2 as follows:  
 
∑ ∫
= +−=
n
j
t
m
jPec DAK
dtV
DAtDA
1 0
max
, 1/
)(  
 
DAinput can be calculated as  
∑
=
=
n
j
jPInput DADA
1
,    (17) 
 
The calculation of GDAT and input dopamine concentration (DAInput ) 
provide data for GDAT modeling. In this model GDAT is a response variable, DAInput 
is an independent variable. The extracellular dopamine concentration was 
calculated for dopamine release rates equal to 6, 7, 8, 9, 10, 25, 45, 60, 90, 120 
pulse/s. The computational data generated by these simulations was used to 
model GDAT as a linear function of DAInput.   
The linear regression modeling was done using Regression Procedure 
(PROC REG, SAS 8.2, SAS Institute). Regression analysis is the analysis of the 
relationship between one variable and another set of variables. The relationship 
is expressed as an equation that predicts a response (dependent) variable as a 
function of predictor (independent) variables. The parameters are adjusted so 
that a measure of fit is optimized [113].  The general form for linear regression 
equation is as follows: 
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 iii XR εββ ++= 10    (18) 
where  Ri  –  response variable; 
Xi  –  predictor  variable; 
β 0 , β1   –  unknown parameters to be estimated; 
εI   – error term. 
 
 
For GDAT  modeling Equation 18 will be as follows: 
 
 iInputDAT DAG εββ ++= 10   (19) 
 
 
 
 
2.3.2 Computational Evaluation of Extracellular Dopamine Concentration   
  Control by DAT Uptake and Receptor Feedback.  
ФReceptor Modeling 
 
  
 
To determine the feedback equation, feedback response was modeled as 
a function of presynaptic D2 receptors (autoreceptors) occupancy by dopamine  
for dopamine release rates from 7 to 120 pulse/s. The assumption was that the 
negative feedback response is evolved to return the extracellular dopamine 
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concentration to basal, 0.022 µM, level. The feedback calculation equation was 
derived from Equation 14 as follows: 
 
DATceptors
DATInput
ec G
GDA
DA
Re1
022.0 Φ+==  
 
DAT
Input
DATec
Input
ceptor G
DA
GDA
DA 1
022.0
1
Re −=−=Φ
=
  (20) 
 
The input dopamine concentration was increased by changing dopamine 
release rates from 7 to 120 pulse/s and corresponding feedback values were 
calculated. 
 
The receptor occupancy (y) for changing input dopamine concentrations 
was calculated according to Law of Mass Action as shown in Equation 5:   
 
][]][[ 21 ykyRzkdt
dy
t −−=  
 
The calculation of feedback values and corresponding receptor occupancy 
for changing input dopamine concentrations generated data used to model the 
feedback as a function of receptor occupancy.  Feedback was modeled as a 
function of receptor occupancy using linear regression (PROC REG, SAS 8.2, 
SAS Institute).  
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For feedback modeling, the response variable is feedback, the predictor 
variable is a receptor occupancy by dopamine. Equation 21 is linear regression 
equation for feedback modeling: 
 
iii y εββ ++=Φ 10   (21) 
 
where  Фi   -  feedback; 
yi  -  receptor occupancy. 
 
 
Equation 22 is a general equation for the extracellular dopamine concentration 
modeling, DAT-R Model:     
 
)(1 210 DDAT
inputDAT
ec yG
DAG
DA ββ ++=   (22) 
 
 
Equation 22 is describing the extracellular dopamine concentration control 
system by DAT uptake and feedback mediated by D2 receptors (presynaptic 
autoreceptors).  
Assuming that  feedback equation is the same for both D2 and D1 
receptors and the proportion of high affinity postsynaptic D1 receptors is 0.35, the 
model for a system with D2 /D1 receptor feedback can be described according to 
Equation 23, DAT-RD2RD1 Model: 
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))35.0(2(1 1210 DDDAT
inputDAT
ec yyG
DAG
DA +++= ββ  (23) 
 
 
Thus, two models considering feedback by either D2 or D2 D1 receptors were 
evaluated: 
 
• DAT- R  Model: Dopamine concentration Control is mediated by 
DAT uptake and presynaptic D2 receptors (autoreceptors); 
 
•  DAT-RD2 RD1 Model: Dopamine concentration Control is mediated 
by DAT uptake, presynaptic D2 receptors (autoreceptors), and D1 
postsynaptic receptors when D2 receptors are fully occupied. 
 
Equation 22 (DAT-R Model) was used to compute the extracellular 
dopamine concentration for dopamine release rates 7, 8, 9, 10, 25, 45, 60, 90, 
and 120 pulse/s. The results of extracellular dopamine concentration calculation 
according to DAT-R model were compared with the results of the extracellular 
dopamine concentration calculation according to DAT control model (Equation 2) 
for dopamine release rates 7, 8, 9, 10, 25, 45, 60, 90, and 120 pulse/s.  
The comparison of DAT and DAT-R model generated results provided the 
computational demonstration of a feedback contribution to the extracellular 
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dopamine concentration control for the conditions of changing input dopamine 
concentrations.    
The review of the experimental literature suggested that the postsynaptic 
feedback mediated by D1 receptors is observed only when the autoreceptors are 
fully occupied.  For modeling purposes, the autoreceptor occupancy by 
dopamine equal to 0.7 was considered as a full occupancy for D2 receptors.  
D1 receptor feedback as an additional mechanism to control the extracellular 
dopamine concentration was mediated only when D2 receptor occupancy by 
dopamine was equal or greater than 0.7. Thus, the modeling of the extracellular 
dopamine concentration according to DAT-RD2 RD1 model, Equation 23, was 
computed when D2 occupancy by dopamine was ≥ 0.7.   
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2.3.3 Estimation of Extracellular Dopamine Concentration   
  Change under Conditions Equivalent to the Presence of Dopamine 
Antagonists/Agonists 
 
 
As dopamine agonists/antagonists are added to the dopaminergic system, 
they are competitively binding to dopamine receptors and mediate feedback 
response. Assumption that basal dopamine concentration is the equilibrium 
concentration for the dopamine system allows estimate the dopamine receptor 
occupancy at the equilibrium as follows: 
 
    
DKL
LOccupancyFractional += ][
][    (24) 
where   [L]   – ligand concentration, µM; 
     KD   – equilibrium dissociation constant, µM. 
 
 
For dopamine system at equilibrium (basal) conditions, basal dopamine 
concentration is equal to 0.022 µM, K =0.023 µM, therefore D2 receptor 
(autoreceptor) occupancy at equilibrium can be estimated to be 0.488 or 48.8%. 
It is expected that in the presence of agonists dopamine model would predict the 
decrease in extracellular vs. basal dopamine concentration, while the presence 
of antagonists would predict the increase in extracellular vs. basal dopamine 
concentration. Figure 7 demonstrates the graphical representation of expected 
outcomes predicted by dopamine concentration control model in the presence of 
dopamine agonists/antagonists.  
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 The addition of dopamine agonists/antagonist Models with (DAT-D2 ) and  
 
 
 
( DAT-D2/D1 ) control were evaluated:  
 
• DAT- D2  Model: Dopamine concentration Control is mediated by 
DAT uptake and presynaptic High-Affinity D2 receptors 
(autoreceptors); 
           + ∞ 
 
        Basal Occupancy 
 
 
Change in  
DAec , % 
         Receptor 
         Occupancy 
    0   0.49   1 by 
         Agonist
  
 
 
 
 
 
 Figure 5. Graphical representation of the expected outcomes predicted by 
dopamine concentration control model in the presence of 
dopamine agonists/antagonists. 
 
 
 
The dopamine concentration control models, both DAT-R and  
DAT-RD2 RD1, were used to estimate the change in the equilibrium extracellular 
dopamine concentration vs. basal dopamine concentration under the conditions 
simulating the presence of Haloperidol (D2 antagonist), SCH23390 (D1 
antagonist), Quinpirole (D2 agonist), and A-77636 (D1 agonist). Table 6 
summarizes dopamine agonists/antagonist characteristics.  
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Table 6.   Characteristics of dopamine agonist/antagonist used for                          
calculation of the extracellular dopamine concentration change in 
the presence of dopamine agonists/antagonists. 
 
KD, 
µM 
 
Dopamine 
Competitor 
 
Type 
D1 D2
 
Haloperidol 
 
Specific D2 Antagonist
 
0 
 
0.0013 
 
Sulpiride 
 
Specific D2 Antagonist
 
0 
 
0.0074 
 
SCH233390 
 
Specific D1 Antagonist
 
0.019 
 
0 
 
Quinpirole 
 
Specific D2 Agonist 
 
0 
 
0.0048 
 
A-77636 
 
Specific D1 Agonist 
 
0.0398 
 
0 
 
 
 
 The equation for the dopamine-receptor occupancy at equilibrium in the 
presence of a competitive antagonist can be described by a classic equation for 
competitive antagonism derived by Gaddum (Equation 25). This equation gives 
fractional receptor occupancy by an agonist at the equilibrium for any given 
concentration of ligand (dopamine) and antagonist.  
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where  ye  – fractional receptor occupancy at equilibrium;    
 [L]  – ligand, dopamine, concentration, µM; 
 [A] – antagonist  concentration, µM; 
  KD,L  – equilibrium ligand, dopamine, dissociation constant, µM; 
 KD,A  – equilibrium antagonist dissociation constant, µM. 
 
 
 Binding of the competitive agonist to dopamine receptors stimulates 
dopamine receptors in the same manner as dopamine binding to receptors. 
Thus, the total receptor occupancy in the presence of agonist is calculated as 
summation of binding due to both dopamine and agonist: 
 
   
)][1(][
][
)][1(][
][
][
][
,
,,
LD
AD
A
LD
e
t
K
LKA
A
K
AKL
Ly
R
LR
++
+
++
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where ye  – fractional receptor occupancy at equilibrium;   
[L]  – ligand, dopamine, concentration, µM; 
 KD,L  – equilibrium ligand, dopamine, dissociation constant, µM. 
[A]   – agonist concentration, µM; 
  K,A  – equilibrium agonist dissociation constant, µM. 
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2.3.4 Modeling Equations for Extracellular Dopamine Concentration   
  Change under Conditions Equivalent to the Presence of 
Antagonists/Agonists 
 
 
For the comparison purposes, the change in the extracellular dopamine 
concentration in the presence of dopamine agonists/antagonists was calculated 
according to both DAT-R and DAT- RD2 RD1 models.  
One of the assumptions for DAT- RD2 RD1 model is that D1 receptor 
feedback is mediated when D2 receptors are fully occupied by dopamine. In the 
presence of D2 antagonists, the D2 occupancy by agonists is always less than 
0.7. However, as D2  antagonist concentration increases the extracellular 
dopamine concentration increases as well. The equilibrium extracellular 
dopamine concentration corresponding to the 0.7 occupancy of D2 receptors by 
dopamine was calculated to be 0.0536 µM according to Equation 24.   
The published experimental data is not specifying if D1 feedback is 
mediated due to the high occupancy of D2 receptors by dopamine or high 
extracellular dopamine concentration. Thus, for the modeling purposes, the 
feedback mediated by D1 receptors was considered in DAT- RD2 RD1 model if D2 
receptor occupancy by dopamine was ≥ 0.7 OR if extracellular dopamine 
concentration was ≥ 0.0536 µM.   
Tables 7, 8, 9 and 10 summarize modeling equations used for calculation 
of the extracellular dopamine concentration in the presence of dopamine 
antagonists. 
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 Table 7.  Modeling equations for the extracellular dopamine concentration 
calculations in the presence of D2 specific antagonists.    
 
 
Antagonist 
 
Model 
 
Modeling Equation 
 
DAT-R 
))0(2(1 210 +++
=
DDAT
inputDAT
ec yG
DAG
DA ββ  
where yD2  -  D2 receptor occupancy by dopamine in the 
presence of D2 antagonists. 
 
 
 
D2 specific 
 
 
 
DAT-RD2 RD1
If the extracellular dopamine concentration is 
< 0.0536 µM then: 
 
))0(2(1 210 +++
=
DDAT
inputDAT
ec yG
DAG
DA ββ  
 
If the extracellular dopamine concentration is 
≥ 0.0536 µM then: 
 
))35.0(2(1 1210 DDDAT
inputDAT
ec yyG
DAG
DA +++= ββ  
where yD2  -  D2 receptor occupancy by dopamine in the 
presence of D2 antagonists; 
yD1  -  D1 receptor occupancy by dopamine. 
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In contrast to D1 receptors, D2 receptors are mediating feedback at any 
changes in the extracellular dopamine concentration vs. basal concentration.  
 
 
Table8.  Modeling equations for the extracellular dopamine concentration 
calculations in the presence of D1 specific antagonists.    
   
 
Antagonist 
 
Model 
 
Modeling Equation 
 
DAT-R ))0(2(1 110 DDAT
inputDAT
ec yG
DAG
DA +++= ββ  
where yD1  -  D1 receptor occupancy by dopamine in the 
presence of D1 antagonists. 
 
 
D1 specific 
  
DAT-RD2 RD1
 
))(2(1 1210 DDDAT
inputDAT
ec yyG
DAG
DA +++= ββ  
where yD2  -   D2 receptor occupancy by dopamine; 
yD1  -  D1 receptor occupancy by dopamine in the 
presence of D1 antagonists. 
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Table 9.  Modeling equations for the extracellular dopamine concentration 
calculations in the presence of D2 specific agonists.    
 
 
Agonist 
 
Model 
 
Modeling Equation 
 
DAT-R 
))0(2(1 210 +++
=
DDAT
inputDAT
ec yG
DAG
DA ββ  
where yD2  -  D2 receptor occupancy by dopamine in the 
presence of D2 agonists. 
 
 
 
D2 specific 
 
 
DAT-RD2 RD1
If D2 occupancy is < 0.7 then: 
 
))0(2(1 210 +++
=
DDAT
inputDAT
ec yG
DAG
DA ββ  
 
If D2 occupancy is ≥ 0.7 then: 
 
))35.0(2(1 1210 DDDAT
inputDAT
ec yyG
DAG
DA +++= ββ  
where yD2  -  D2 receptor occupancy by dopamine in the 
presence of D2 agonists; 
yD1  -  D1 receptor occupancy by dopamine. 
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Table8.  Modeling equations for the extracellular dopamine concentration 
calculations in the presence of D1 specific agonists.    
   
 
Agonist 
 
Model 
 
Modeling Equation 
 
DAT-R ))0(2(1 110 DDAT
inputDAT
ec yG
DAG
DA +++= ββ  
where yD1  -  D1 receptor occupancy by dopamine in the 
presence of D1 agonists. 
 
 
D1 specific 
  
DAT-RD2 RD1
 
))(2(1 1210 DDDAT
inputDAT
ec yyG
DAG
DA +++= ββ  
where yD2  -   D2 receptor occupancy by dopamine; 
yD1  -  D1 receptor occupancy by dopamine in the 
presence of D1 agonists. 
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3.  RESULTS 
 
3.1  DOPAMINE CONCENTRATION CONTROL: DAT UPTAKE MODEL 
(Kinetic Model)   
 
3.1.1   Evaluation of Dopamine System Response to Changing Dopamine         
Release Rates, DAT Model 
  
In order to demonstrate dopamine concentration control by DAT uptake 
only, the extracellular dopamine concentration was estimated according to 
Equation 2 (DAT Model): 
 
∑ ∫
= +−=
n
j
t
m
jPEC DAK
dtV
DAtDA
1 0
max
, 1/
)(  
 
Equation 2 was used to calculate the extracellular dopamine concentration at the 
following dopamine release rates: 120, 90, 60, 45, 25, 10, 9, 8, 7, and 6 pulse/s 
(Table 7).  The dopamine concentration per pulse was 0.049 µM.  The 
extracellular dopamine concentration profile is shown for the dopamine release 
rates 120, 25, 8, 7, 6 pulse/s and 5 sec of dopamine release (Figures 6, 7, 8, 9, 
10). 
 
 63
Extracellular Dopamine Concentration, DAT Model 
Dopamine Release Rate=120 pulse/s
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Figure 6. Extracellular Dopamine Concentration Control Predicted by       
DAT Model. Dopamine Release Rate=120 pulse/s. 
 
 
Extracellular Dopamine Concentration, DAT Model 
Dopamine Release Rate=45 pulse/s
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0.2
0 0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 5.5
Time,s
D
op
am
in
e 
C
on
ce
nt
ra
tio
n 
M
x1
0-
6.
 
 
Figure 7. Extracellular Dopamine Concentration Control Predicted by       
DAT Model. Dopamine Release Rate=45 pulse/s. 
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Extracellular Dopamine Concentration, DAT Model. 
Dopamine Release Rate=8 pulse/s
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Figure 8. Extracellular Dopamine Concentration Control Predicted by       
DAT Model. Dopamine Release Rate=8 pulse/s. 
 
 
Extracellular Dopamine Concentration Control, DAT Model. 
Dopamine Release Rate=7pulse/s 
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Figure 9. Extracellular Dopamine Concentration Control Predicted by       
DAT Model. Dopamine Release Rate=7 pulse/s. 
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 Extracellular Dopamine Concentration, DAT Model. 
Dopamine Release Rate=6 pulse/s
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Figure 10. Extracellular Dopamine Concentration Control Predicted by       
DAT Model. Dopamine Release Rate=6 pulse/s. 
 
 
 
The graphs on Figures 6, 7, 8, 9, and 10 demonstrate that the DAT model 
predicted three types of dopamine concentration control outcomes in response to  
changing dopamine release rates: uncontrolled dopamine concentration change 
(increase or decrease) – system unstable (Figures 6 and 10); linear dopamine 
concentration increase (Figure 7) or oscillatory dopamine concentration change 
(Figure 8) followed by stable concentration – system stable; oscillatory change in 
dopamine concentration – system at critical condition (Figure 9).
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Table 11 summarizes computational results for the extracellular dopamine 
concentration predicted by DAT model.  
 
Table 11.  Extracellular Dopamine Concentration Predicted by DAT Model 
for Dopamine Release Rates from 6 to 120 pulse/s. 
Dopamine 
Release 
Rate,  
pulse/s 
Dopamine Concentration 
Control System Response 
Settling 
time,   
s 
Average Extracellular 
Dopamine 
Concentration,  
µM 
 
120 
 
No Control, Linear 
concentration increase 
 
N/A ∞+  
 
90 
 
Linear increase followed by 
stable concentration  
 
4.90 
 
1.107 
 
60 
 
Linear increase followed by 
stable concentration 
 
1.58 
 
0.302 
 
45 
 
Linear increase followed by 
stable concentration 
 
0.58 
 
0.181 
 
25 
 
Linear increase followed by 
stable concentration 
 
0.36 
 
0.092 
 
10 
 
Linear increase followed by 
stable concentration 
 
0.30 
 
0.083 
 
8 
 
Oscillation followed by 
stable concentration 
 
2.00 
 
0.149 
 
7 
 
Oscillation  
 
N/A 
 
0.430 
 
6 
 
No Control, Linear 
concentration decrease 
 
N/A  ∞−  
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The DAT model predicted that the dopamine concentration control system 
would be unstable for dopamine release rates ≥ 120 pulse/s or ≤ 6pulse/s; the 
dopamine concentration control system would be stable for dopamine release 
rates 8-110 pulse/s; and the dopamine concentration control would be in the 
critical condition for dopamine release rate 7 pulse/s.   
The dopamine concentration estimation computational results also 
suggested that dopamine release rate equal to10 pulse/s would provide the best 
fit to the physiological conditions for the dopamine system. At a release rate 
equal to 10 pulse/s, the model generated data predicted the shortest settling time 
(0.3 s) and the closest level of predicted extracellular dopamine concentration 
(0.083 µM) to basal level (0.022µM). This computationally determined basal 
dopamine release rate of 10 pulse/s is comparable with the basal dopamine 
release rate of 5-10 pulse/s reported in the published experimental studies  [31, 
106].  
The important observation based on DAT model generated results was 
that while DAT uptake provides control to extracellular dopamine concentration, 
DAT uptake alone is not sufficient to maintain a low basal extracellular dopamine 
concentration. The application of the experimental literature reported parameters 
of dopamine system for DAT model, predicted basal extracellular dopamine 
concentration to be equal to 0.083 µM. This is 4 times higher compared to the 
experimentally reported basal extracellular dopamine concentration of 0.022 µM. 
Thus, the presence of an additional mechanism (feedback) to maintain low basal 
dopamine concentration was demonstrated computationally.  
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3.1.2 GDAT Modeling as a Function of Input Dopamine Concentration 
 
 
For each dopamine release rate tested, GDAT  was calculated according to 
Equation 16: 
 
Input
ec
DAT DA
DA
G =  
 
Input dopamine concentration was calculated according to Equation 17: 
 
 
∑
=
=
n
j
jPInput DADA
1
,  
 
 
Gdat modeling was done using computational data for dopamine release 
rates 8, 9, 10, 25, 45, 60, and 90 pulse/s (Figure 11).  The computational data for 
dopamine release rates at 7 and 120 pulse/s was excluded from the modeling to 
maximize R2  for the GDAT model.  
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Figure 11.  GDAT Modeling as a Function of Input Dopamine Concentration. 
 
 
Equation 27 is a linear regression model for GDAT as a function of input dopamine 
concentration, R2 =0.931 
    
   036.1356.1 += InputDAT DAG   (27) 
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 3.2 DOPAMINE CONCENTRATION CONTROL:  DAT UPTAKE and 
RECEPTOR FEEDBACK MODEL 
 
 
3.2.1 D2 Receptor Feedback Modeling  
 
The feedback modeling was based on the assumption that D2 presynaptic 
receptors (autoreceptors) are the principal receptors responsible for controlling 
the low basal extracellular dopamine concentration and its return to the 
physiological level under the conditions of a fluctuating extracellular dopamine 
concentration. The feedback response was modeled for dopamine release rates 
from 7 to 120 pulse/s and calculated according to Equation 18: 
 
 
DAT
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DA
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The feedback was modeled as a function of D2 receptor occupancy using 
the linear regression modeling. D2 receptor occupancy was calculated for 
according to Equation 5 for computational simulations where dopamine release 
rates were changing from 7 to 120 pulse/s: 
   
][]][[ 21 ykyRzkdt
dy
t −−=  
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Figure 12.  Feedback Modeling as a Function of D2 Receptor Occupancy by 
Dopamine/Dopamine Agonists. 
 
 
 
Equation 28 is a linear regression model for feedback as a function of D2 
receptor occupancy by dopamine/dopamine agonists, R2 =0.9857 
    
   2638.23995.0 Dy+−=Φ   (28) 
   where yD2   - D2 receptor occupancy 
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3.2.2 DAT-R Model Testing  
 
The feedback modeling equation, Equation 28, was used in the general 
model of the extracellular dopamine concentration (DAT-R model) to calculate 
the extracellular dopamine concentration for dopamine release rates from 7-120 
pulse/s. 
 
)638.23995.0(1 2DDAT
inputDAT
ec yG
DAG
DA +−+=   (29) 
     
The extracellular dopamine concentration profiles estimated by DAT-R model are 
shown for dopamine release rates 7, 8, 10, and 120 pulse/s and 5 sec of 
dopamine release (Figures 13, 14, 15, and 16). The extracellular dopamine 
concentration control graphs for model with DAT uptake and D2 feedback    
demonstrate that receptor feedback is an essential mechanism maintaining  
extracellular dopamine concentration at a low physiological level and it minimizes 
the deviation around the extracellular dopamine concentration.  
For example, computational results demonstrated that the DAT model was not 
able to maintain the extracellular dopamine concentration at low, 0.022 µM, 
which is the level reported in the experimental literature. In contrast, DAT-R 
model, predicted the extracellular dopamine concentration close to the 
experimentally reported extracellular dopamine level for dopamine release rates 
from 7-120 pulse/s (Table 8).       
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Figure 13. Extracellular Dopamine Concentration Control Predicted by         
DAT-R Model. Dopamine Release Rate=7 pulse/s. 
 
 
Extracellular Dopamine Concentration Control, DAT-R Model. 
Dopamine Release Rate=8 pulse/s
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Figure 14. Extracellular Dopamine Concentration Control Predicted by         
DAT-R Model. Dopamine Release Rate=8 pulse/s. 
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Extracellular Dopamine Concentration Control, DAT-R Model. 
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Figure 15. Extracellular Dopamine Concentration Control Predicted by         
DAT-R Model. Dopamine Release Rate=10 pulse/s. 
 
 
Extracellular Dopamine Concentration Control, DAT-R Model. 
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 Figure 16. Extracellular Dopamine Concentration Control Predicted by           
DAT-R Model. Dopamine Release Rate=120 pulse/s. 
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Table 12 summarizes data about the computed average dopamine concentration 
and concentration deviation for DAT and DAT-R models.   
 
Table 12. Extracellular Dopamine Concentration: DAT vs. DAT-R Models.   
Note: Basal Extracellular Dopamine Concentration is 0.022µM.  
 
 
DAT Model 
 
DAT-R Model 
 
Dopamine 
Release 
Rate, 
pulse/s 
 
Average  [DA] Ec, µM 
and Std. Deviation, % 
 
Average [DA] Ec, µM 
and Std. Deviation, % 
 
6 
 
∞−  
 
0.018 +/-1.12% 
 
7 
 
0.430 +/- 12.8% 
 
0.0196 +/- 1.38% 
 
8 
 
0.149 +/- 6.38% 
 
0.0210+/- 1.05% 
 
10 
 
0.083 +/-0.15% 
 
0.0237+/- 0.92% 
 
25 
 
0.092 +/-0.23% 
 
0.0250+/- 0.68% 
 
45 
 
0.181 +/-0.42% 
 
0.0232+/- 0.40% 
 
60 
 
0.302 +/- 0.56% 
 
0.0224+/- 0.29% 
 
90 
 
1.107 +/-1.25% 
 
0.0214+/- 0.17% 
 
120 
 
∞+  
 
0.0213+/- 0.13% 
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3.2.3 Extracellular Dopamine Concentration Change as a Function of D2 
Receptor Occupancy by Dopamine/Dopamine Agonists, DAT-R 
Model 
 
Equation 29 allows us to analyze the possible range of the extracellular 
dopamine concentration change as the D2 receptor occupancy changes from 0 to 
1.  The model predicted change in the extracellular dopamine concentration was 
calculated according to Equation 30: 
  
%100
022.0
)022.0( , •−=Δ ModelEcEc DADA   (30) 
 
where  ∆DAEc  -change in the extracellular dopamine 
concentration vs. basal extracellular dopamine 
concentration, %; 
 DAEc,Model  -model calculated extracellular dopamine 
concentration, µM; 
 0.022   -literature reported basal extracellular 
dopamine concentration, µM.  
  
The calculation of the extracellular dopamine concentration change 
demonstrated that the DAT-R model predicts the increase of extracellular 
dopamine concentration by 338.8% vs. the basal concentration when the D2 
receptor occupancy by agonists was equal to 0, i.e. conditions when D2 receptors 
were completely occupied by dopamine antagonists. The decrease in  
extracellular dopamine concentration was predicted to be -29.2% from the basal 
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concentration    when D2 receptor occupancy by agonists was equal to 1.0, i.e. 
conditions when D2 receptors were completely occupied by dopamine/dopamine 
agonists (Figure 17).   
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Figure 17. Extracellular Dopamine Concentration Change Predicted by         
DAT-R Model as a Function of D2 Occupancy by 
Dopamine/Dopamine Agonists. 
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3.2.4 Extracellular Dopamine Concentration Change as a Function of D2 
Receptor Occupancy by Dopamine/Dopamine Agonists, DAT-RD2RD1 
Model 
 
 
 
The results of the change in extracellular dopamine concentration 
predicted by the DAT-R model demonstrated that the decrease in extracellular 
dopamine concentration was not as low as was reported in the published 
experimental literature for conditions of high D2 agonist concentrations, i.e. when 
D2 occupancy by agonists is high. This suggests that the computational model 
with an additional feedback should be considered.  
The model assumption is that D1 receptor control is mediated when D2 
receptor occupancy is ≥ 0.7 OR the extracellular dopamine concentration is ≥ 
0.0536 µM. The following are model equations considering both presynaptic and 
postsynaptic receptor feedback, DAT-RD2RD1 model: 
 
1. If D2 receptor occupancy is < 0.7 then extracellular dopamine concentration 
is calculated according to Equation 29:   
 
)638.23995.0(1 2DDAT
inputDAT
ec yG
DAG
DA +−+=  
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2. If D2 receptor occupancy is  ≥ 0.7 or  the extracellular dopamine 
concentration is  ≥ 0.0536 µM then feedback is calculated as: 
 
)(638.2799.0)638.23995.0()638.23995.0( 1212 DDDD yyyy ++−=+−++−=Φ  (31) 
 
Also, an additional model assumption is that 0.35 of D1 postsynaptic receptors 
are high affinity receptors.  Therefore, the extracellular dopamine concentration 
according to the DAT-RD2RD1 Model can be calculated according to Equation 32:   
 
))35.0(638.2799.0(1 12 DDDAT
inputDAT
ec yyG
DAG
DA ++−+=  (32) 
 
The extracellular dopamine concentration according to DAT-RD2RD1 model was 
calculated assuming that postsynaptic receptors involved into extracellular 
dopamine concentration control have the same affinity, and therefore occupancy   
as D2 presynaptic receptors. The calculation of  extracellular dopamine 
concentration change using the DAT-RD2RD1 model demonstrated that this model 
predicted the increase of extracellular dopamine concentration by 338.8% vs. the 
basal concentration when D2 receptor occupancy by agonists was equal to 0. 
The decrease in extracellular dopamine concentration was predicted to be           
-39.3% from the basal concentration when D2 receptor occupancy by agonists 
was equal to 1.0, i.e. conditions when D2 receptors were completely occupied by 
dopamine/dopamine agonists (Figure 18).   
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Figure 18. Extracellular Dopamine Concentration Change Predicted by         
DAT-RD2RD1 Model as a Function of D2 Occupancy by 
Dopamine/Dopamine Agonists. 
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3.3  MODELING of EXTRACELLULAR DOPAMINE CONCENTRATION   
 UNDER CONDITIONS EQUIVALENT TO THE PRESENCE   
 OF DOPAMINE ANTAGONISTS/AGONIST 
 
 
To evaluate the developed model performance, extracellular dopamine 
concentration under conditions equivalent the presence of dopamine 
antagonists/agonists was predicted using both, the DAT-R and DAT-RD2RD1 
models, and compared with experimental literature data for extracellular 
dopamine concentration in the presence of dopamine agonists/antagonists.   
 
 
 
3.3.1 Model Predicted Extracellular Dopamine Concentration Change in 
the Presence of Dopamine Antagonists 
 
 
D2 Antagonists 
 
The extracellular dopamine concentration in the presence of Haloperidol 
was calculated to estimate the change in dopamine concentration vs. basal 
concentration in the presence of selective D2 antagonists.  
As D2 antagonist concentration increases, D2 occupancy by dopamine 
decreases which leads to an increase in the extracellular dopamine 
concentration vs. basal dopamine concentration.  When the extracellular 
dopamine concentration is high, ≥ 0.0536 µM, the postsynaptic D1 receptors 
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mediate feedback, which is opposite to feedback mediated by D2 receptors. The 
existence of both D2 and D1 receptor feedback is addressed in DAT-RD2RD1 
model. Table 13 summarizes computational data for the model predicted 
extracellular dopamine concentration change vs. basal in the presence of 
Haloperidol. 
 
Table 13.  Model Predicted Extracellular Dopamine Concentration Change in 
the Presence of Haloperidol, KD =1.3 nM 
Extracellular Dopamine Concentration vs. Basal 
Dopamine Concentration, % 
 
Haloperidol 
Concentration, 
µM 
 
DAT-R Model
 
DAT-RD2RD1 
Model 
Experimental 
Published Data, 
[26, 98, 115] 
 
 
0.003 
 
202.6 
 
202.6 
 
138.4 
 
0.005 
 
236.3 
 
236.3 
 
Not Available  
 
0.100 
 
412.8 
 
254.0 
 
Not Available 
 
1.000 
 
435.9 
 
260.2 
 
250.0 
 
 
The model generated results predicted an increase in extracellular 
dopamine concentration vs. basal in the presence of Haloperidol. The 
computational results produced by the DAT-RD2RD1 model, however, were in 
better accordance with the experimentally reported increase in the extracellular 
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dopamine concentration.  The DAT-RD2RD1 model demonstrated an increase in 
the extracellular dopamine concentration from 202.6% to 260.2% from the basal 
concentration as Haloperidol concentration was increased from 0.003 to 1.0 µM. 
The literature reported extracellular dopamine concentration change for 
Haloperidol concentrations equal to 0.003 µM and 1.0 µM was from 138.4% to 
250.0% [25, 115]. Thus, the contribution of postsynaptic feedback mediated by 
D1 receptors in control of the extracellular dopamine concentration was 
demonstrated computationally.  
  
D1 Antagonists 
 
The extracellular dopamine concentration in the presence of SCH23390 
was calculated to estimate the change in dopamine concentration vs. basal 
concentration in the presence of selective D1 antagonists. As D1 antagonist 
concentration increases, the D1 occupancy by dopamine decreases leading to an 
increase in extracellular dopamine concentration vs. basal dopamine 
concentration.  The increase in extracellular dopamine concentration results in 
the increase of D2 receptor occupancy by dopamine mediating D2 receptor 
feedback opposite to the feedback mediated by D1 receptors.  The DAT-RD2RD1 
model assumes that, in contrast to D1 receptors mediating feedback only at high 
extracellular dopamine concentration or high D2 receptor occupancy by 
dopamine, D2 receptor feedback response is observed with any change in the 
extracellular dopamine concentration.  Table 14 summarizes computational data 
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for the model predicted extracellular dopamine concentration in the presence of 
SCH233390. 
 
Table 14.  Model Predicted Extracellular Dopamine Concentration Change in 
the Presence of SCH233390, KD =19.0 nM 
Extracellular Dopamine Concentration vs. Basal 
Dopamine Concentration, % 
 
SCH233390 
Concentration, 
µM 
 
DAT-R Model 
DAT-RD2RD1 
Model 
Experimental 
Published Data, [73]  
 
0.01 
 
146.2 
 
83.7 
 
Not Available 
 
1.00 
 
402.2 
 
99.1 
 
Not Available 
 
10.00 
 
434.7 
 
99.5 
 
Not Available 
 
200.00 
 
438.6 
 
99.5 
 
443.9 
 
The DAT-R model generated results demonstrated an increase in  
extracellular dopamine concentration from 146.2% to 438.6 % from the basal 
concentration as SCH233390 concentration was increased from 0.01 to 200 µM.  
The DAT-RD2RD1 model generated results, however, predicted a decrease in the 
extracellular dopamine concentration in the presence of 0.01 µM of SCH233390. 
At higher concentrations of SCH233390, the computationally estimated 
extracellular dopamine concentration was close to the basal dopamine 
concentration.   In an experimental literature, there was a 443.9% increase in 
dopamine concentration in the presence of 200 µM of SCH23390 [73].    
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3.3.2 Model Predicted Extracellular Dopamine Concentration Change in 
the Presence of Dopamine Agonists 
 
 
D2 Agonists 
 
Extracellular dopamine concentration in the presence of Quinpirole was 
calculated to estimate the change in dopamine concentration vs. basal 
concentration in the presence of selective D2 agonists. As D2 agonist 
concentration increases, the D2 receptor mediated feedback leads to a decrease 
in extracellular dopamine concentration vs. basal dopamine concentration.  
Further, the model assumption is that when D2 receptor occupancy by 
dopamine/dopamine agonists increases up to 0.7, the postsynaptic D1 receptors 
start mediating feedback as an additional mechanism to control extracellular 
dopamine concentration. The feedback mediated by D1 receptors is a function of 
D1 receptor occupancy by dopamine. In the presence of D2 agonists the 
extracellular dopamine concentration decreases, thus postsynaptic feedback 
mediated by D1 receptors would be opposite to the feedback mediated by D2 
receptors. The existence of both D2 and D1 receptor feedback is addressed in 
DAT-RD2RD1 model. Table 15 summarizes computational data for the model 
predicted extracellular dopamine concentration in the presence of Quinpirole. 
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Table 15.  Model Predicted Extracellular Dopamine Concentration 
Change in the Presence of Quinpirole, KD =4.8 nM 
Extracellular Dopamine Concentration vs. Basal 
Dopamine Concentration, % 
 
Quinpirole 
Concentration, 
µM 
 
DAT-R Model 
DAT-RD2RD1 
Model 
Experimental 
Published Data, 
[25, 98, 115] 
 
0.050 
 
75.95 
 
76.24 
 
67.8    
 
0.455 
 
71.43 
 
71.99 
 
Not Available 
 
1.00 
 
71.09 
 
71.68 
 
Not Available 
 
10.00 
 
70.84 
 
71.44 
 
41.1 
 
 
The model generated results predicted a decrease in the extracellular 
dopamine concentration vs. basal in the presence of Quinpirole.  
The computational results calculated by the DAT-R model predicted a decrease 
in the extracellular dopamine concentration from - 24.05%  to -29.17%  vs. basal 
concentration for Quinpirole concentration range from 0.05 to 10.0 µM.  
The computational results calculated by the DAT-RD2RD1 model predicted a 
decrease in extracellular dopamine concentration from - 23.76%  to -28.56%  vs. 
basal concentration for Quinpirole concentration range from 0.05 to 10.0 µM.  
The literature reported extracellular dopamine concentration change for 
Quinpirole concentrations 0.05 µM and 1.0 µM was from -32.2%  
to  -58.9% [25, 115].  
 87
D1 Agonists 
 
The extracellular dopamine concentration in the presence of A-77636 was 
calculated to estimate the change in dopamine concentration vs. basal 
concentration in the presence of selective D1 agonists.  As D1 agonist 
concentration increases, the D1 receptor mediated feedback leads to the 
decrease in the extracellular dopamine concentration vs. basal dopamine 
concentration.  In case of DAT-RD2RD1 model, the decrease in the extracellular 
dopamine concentration would activate D2 receptor feedback leading to the 
opposite feedback increasing the extracellular dopamine concentration. Table 16 
summarizes computational data for the model predicted extracellular dopamine 
concentration in the presence of A-77636. 
 
Table 16.  Model Predicted Extracellular Dopamine Concentration Change in 
the Presence of A-77636, KD =39.8 nM 
Extracellular Dopamine Concentration vs. 
Basal Dopamine Concentration, % 
 
A-77636 
Concentration, 
µM 
 
DAT-R Model 
 
DAT-RD2RD1 
Model 
Experimental 
Published 
Data,  
[73] 
 
0.01 
 
114.18 
 
76.06 
 
Above Basal 
Concentration 
 
1.05 
 
72.97 
 
59.59 
 
 
Not Available 
 
5.05 
 
71.27 
 
58.69 
 
Not Available 
 
9.95 
 
71.04 
 
58.57 
 
80.0 
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The model generated results predicted a decrease in extracellular 
dopamine concentration vs. basal in the presence of A-77636. The computational 
results calculated by the DAT-R model predicted a decrease in extracellular 
dopamine concentration. The extracellular dopamine concentration was 
estimated to be from 72.97% to 71.04% vs. basal concentration for A-77636 
concentration from 1.05 to 9.95 µM. At low, 0.01µM, A-77636 concentration   
DAT-R model, however, predicted an increase in extracellular dopamine 
concentration up to 114.18% vs. basal dopamine concentration. 
The computational results calculated by the DAT-RD2RD1 model also 
predicted a decrease in extracellular dopamine concentration. This decrease in 
extracellular dopamine concentration was predicted to be greater when 
compared to the DAT-R model. The extracellular dopamine concentration was 
estimated to be in the range of 76.06% to 58.57% vs. basal concentration for A-
77636 concentration from 0.01 µM to 9.95 µM.  
The published experimental data reported extracellular dopamine 
concentration around 80% vs. basal in the presence of high A-77636 
concentration. A trend toward an increase in dopamine concentration was shown 
for lower A-77636 concentrations [73].   
 
 
  .  
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4. DISCUSSION 
 
 
The extracellular dopamine concentration control model incorporating 
dopamine release, DAT uptake, and receptor negative feedback mechanisms 
was developed in this thesis work. This is the first model providing a 
computational description and evaluation for the complex mechanisms of  
extracellular dopamine concentration control. The novelty of this computational 
study is that it considers both DAT uptake and negative receptor feedback as 
mechanisms of the dopamine concentration control in a single mathematical 
model. Further, this developed model considers both presynaptic and 
postsynaptic extracellular dopamine concentration control by negative feedback. 
 The modeling data was obtained from the published literature and 
computational simulations. The experimental literature data provided parameter 
values for the modeling.  
Three series of computer simulations were done in this modeling: the 
simulation of extracellular dopamine control by DAT uptake; the simulation of  
extracellular dopamine control by DAT and feedback; and the simulation of  
extracellular dopamine concentration control under conditions equivalent to the 
agonist/antagonist presence in the dopamine system. The data generated by the 
first series of modeling considered the dopamine concentration control by release 
and uptake and was to model DAT transfer function (GDAT ) as a function of the 
input dopamine concentration.  The data generated by the second series of 
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modeling considered negative feedback as an additional mechanism of the 
extracellular dopamine concentration control. This data was used to describe 
feedback function (ФReceptor) as a function of the receptor occupancy by 
dopamine. The instantaneous receptor occupancy by dopamine was calculated 
according the Law of Mass Action.  Finally, in the third series of the 
computational modeling, the developed model was used to predict: 
• Outcomes of the extracellular dopamine concentration control under 
conditions of the fluctuating input dopamine release;  
• Extracellular dopamine concentration change vs. basal dopamine 
concentration under the conditions equivalent to the presence of 
agonists/antagonists in dopamine system. This computational data provided 
information about the model performance, i.e. how computational results are 
close to the experimentally observed data.   
The present study is an example of the mathematical modeling for the 
biological system. The mathematical modeling combines quantitative data with a 
qualitative understanding to produce an explanatory and predictive tool. The  
goal of the model is to be rich enough to capture the complex biological system 
phenomenon, while remaining simple enough to provide a tool for repetitive 
computational analysis.  The developed model is an example of interdisciplinary 
research work, i.e. it involves the integration of mathematical modeling 
knowledge, understanding of the underlying biological mechanisms described by 
computational model, computational skills to write and test a computer program, 
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and data analysis.  The general framework of modeling involves the following 
basic steps [6, 67]: 
 
1. Ability to identify the biological question which is a subject of the 
mathematical modeling;  
2. Formulation of the conceptual model, describing the biological 
system;  
3. Identification of dependent and independent model variables; 
4. Conversion of the conceptual model to the mathematical model and 
developing a computer program as a computational tool for model 
testing; 
5. Allocation of data sources and model parameters; 
6. Model analysis and evaluation, i.e. an assessment of the model 
ability to predict biological system outcomes to be close to the 
experimentally observed data.             
 
All these basic modeling steps were part of the thesis study: 
 
1. The complex mechanism responsible for the extracellular 
dopamine concentration control was a biological question for the 
mathematical modeling. 
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2. The mechanism of extracellular dopamine concentration control 
was conceptualized as a system with dopamine release, uptake, 
and receptor feedback as a negative feedback loop.    
3. Independent variables for the model were: input dopamine release 
rate; released dopamine concentration; parameters for dopamine 
uptake; and parameters for dopamine binding to receptors.         
The extracellular dopamine concentration was a dependent 
variable. 
4. SAS program was developed as a computational tool for the model 
implementation and testing. SAS program was written as a 
MACRO. The independent model variables were MACRO 
parameters. 
5. The published experimental data and program generated 
computational data were two data sources for the modeling.              
The parameters for the dopamine system in rat striatum were used 
for modeling purposes because this data is the most abundant in 
published experimental literature. 
6. Model performance was evaluated to predict the extracellular 
dopamine concentration in response to changing dopamine 
release rates; and under conditions equivalent to the presence of 
agonists/antagonists in dopamine system. The model-generated 
computational data was compared vs. experimental published 
data.     
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As a summary, Figure 19 provides a diagram for dopamine concentration control 
model and variables: 
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Figure 19.  Extracellular Dopamine Concentration Control: Model and 
Variables.  
 
 94
The literature review demonstrated that there are two general modeling 
approaches used to describe control of the extracellular dopamine concentration: 
kinetic model [110, 111, 113, 114] and receptor feedback model [96, 97, 98, 99, 
100].   
The kinetic model was developed by Wightman and Zimmerman in 1988.            
The kinetic modeling describes extracellular dopamine concentration as the 
balance between the opposing actions of the discrete dopamine release and 
continuous dopamine uptake. The kinetic model is based on three parameters: 
one for dopamine release – dopamine concentration released per pulse (DAp,), 
and two parameters for dopamine uptake Km and Vmax for DAT.   The attractive 
feature of this model is that it enables characterization of dopamine concentration 
over a wide range of simulation conditions with the use of three kinetic 
parameters. However, the kinetic model authors acknowledged that in spite of 
the success of the kinetic model to predict the results obtained in vivo, it is clearly 
an oversimplication and will require substantial modification to completely 
describe the complex dopaminergic transmission controlled in a number of ways 
[110, 111].     
The feedback model was introduced by Tallarida in 1990. In this model, 
the ligand (dopamine) concentration is controlled by a feedback signal whose 
intensity is a function of the receptor occupancy by ligand. The ligand binding to 
receptor occurs according to Mass Action Law. It was shown mathematically that 
the extracellular ligand concentration is under negative feedback control, 
meaning that as receptor occupancy increases, the feedback decreases.    
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The thesis developed model for the extracellular dopamine concentration 
control integrated the kinetic and feedback methods in a single model as 
negative feedback system. 
The framework of the kinetic modeling provided a computational basis for 
estimation of extracellular dopamine concentrations under the conditions of 
changing dopamine release rates, 6-120 pulse/s. This estimate demonstrated  
that DAT uptake is not a sufficient mechanism to maintain extracellular dopamine 
concentration at a low basal level under conditions of fluctuating dopamine input. 
The computational data predicted that at dopamine release rates 8-100 pulse/s, 
extracellular dopamine concentration reached a plateau due to  a balance 
between the dopamine release and uptake (Figures 7, 8 ). The results of the 
kinetic model simulations demonstrated that at dopamine release rates ≤ 6 
pulse/s, the dopamine uptake is faster vs. dopamine release (Figure 10). 
Theoretically this computational observation predicted the diminishing of the 
extracellullar dopamine from the synaptic cleft at low dopamine release rates. On 
the other hand, the computational simulations predicted that at dopamine release 
rates ≥ 120 pulse/s, the dopamine release is faster vs. dopamine uptake leading 
to the infinite increase in the extracellular dopamine concentration (Figure 6).    
The review of the experiment published data suggested that the 
physiological dopamine release rate range is between 5-20 pulse/s.  
Physiological dopamine release rate exceeding 100 pulse/s was observed in 
putative dopamine neurons [14, 114].  From the evolutionary perspective it is 
expected that the dopamine system would adapt to maintain a homeostatic 
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extracellular dopamine concentration at the wide range of dopamine release 
rates observed physiologically as the biological system behavior changes. The 
estimation of the extracellular dopamine concentrations according to the kinetic 
model, demonstrated that the extracellular dopamine concentration control was 
present for the dopamine release rate range of 8-100 pulse/s. At higher or lower 
dopamine release rates, the kinetic model predicted the loss in the extracellular 
dopamine concentration control.  Further, the extracellular dopamine 
concentration was calculated to be 0.083 – 0.092 nM for the physiological 
dopamine release rates of 10-25 pulse/s according to the kinetic model and using 
literature reported parameters for the dopamine release and uptake. This 
predicted extracellular dopamine concentration is about 4 times higher 
comparing with an average extracellular basal dopamine concentration reported 
in the experimental data. Therefore, the data generated by the simulations of the 
kinetic model provided the computational evidence that an additional mechanism 
mediating the extracellular dopamine concentration control under the conditions 
of low/high dopamine release rates and tuning the extracellular dopamine 
concentration to the basal level at the physiological dopamine release rates is 
needed together with dopamine release and uptake mechanisms.      
The literature review demonstrated that receptor-mediated control plays 
an important role in dopamine neurotransmission. The recent experimental 
evidence suggested that release and uptake, key mechanisms determining brain 
extracellular level of the dopamine, are governed by presynaptic autoreceptors.  
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The gene deletion experimental work revealed an intimate association among 
DAT, autoreceptors, and dopamine homeostasis [10, 63, 40, 76, 114].     
The mathematical work by Tallarida provided the theoretical foundation for 
the dopamine receptor feedback modeling. Released dopamine interacts with 
dopamine receptors generating feedback which is controlling the extracellular 
dopamine concentration. It was shown mathematically that the dopamine 
receptor feedback is a negative feedback and it could be modeled as a function 
of dopamine receptor occupancy by dopamine [96, 97, 98, 99, 100, 101].  
The negative feedback is the process of feeding back to the input a part of 
a system's output to reverse the direction of change of the output. This tends to 
keep the output from changing, so it is stabilizing and attempts to maintain 
homeostasis. The concept of feedback is a key explanatory idea in 
understanding of the dynamic process in the world.  The self-preservation of 
living organisms in evolution can be described by the negative feedback system.  
The advantage of feedback control is that it leads to increased accuracy, 
effective disturbance reduction, and accelerated speed of response to 
disturbances. The loss of homeostatic ability puts the system into a condition of 
chaos which is defined as unforeseen behavior, i.e. behavior ruled by 
deterministic laws. Generally, the negative feedback loops result in homeostasis. 
Many phenomena, however, observed in the control of biological systems 
demonstrate that negative feedback and homeostasis are not identical. Negative 
feedback is necessary for homeostasis, but may not always be sufficient [21, 25, 
75, 91].    
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The thesis model was developed on the literature supported assumption 
that the dopaminergic system in living organisms was evolved to maintain low 
dopamine concentration and, therefore, any disturbances from the physiological 
dopamine concentration would result in the system behavior to return the 
extracellular dopamine concentration to specific physiological concentration. 
Based on the published experimental literature data, the basal extracellular 
dopamine concentration for modeling was defined as 22.0 nM.  Thus, the 
feedback modeling was done to return system to 22.0 nM for the computational 
simulations where input dopamine concentration was either increased or 
decreased.  The model considering only receptor feedback control was not 
tested because the experimental published data demonstrated that the presence 
of DAT is a necessary component of the extracellular dopamine concentration 
control. The experimental work assessing the extracellular dopamine 
concentration control in mice lacking DAT demonstrated the persistent elevation 
of the extracellular dopamine despite of an intact autoreceptors [40].  
Overall, the published experimental and generated computational data 
suggested that both DAT uptake and receptor feedback are necessary 
mechanisms providing the extracellular dopamine concentration control.       
Thus, a single model integrating both kinetic and feedback mechanisms was 
proposed and developed in the present study. The general concept of a negative 
feedback loop was used to develop a single model integrating both kinetic and 
feedback mechanisms. In this feedback system, dopamine is discretely released 
into synaptic cleft, DAT uptakes the released dopamine,  and the dopamine 
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receptor feedback provides further control to the extracellular dopamine 
concentration to bring it to the physiological level.  The receptor feedback is a 
function of receptor occupancy of dopamine and it is independent of the DAT 
properties.   
To test the computational model integrating DAT uptake and D2 receptor 
feedback (DAT-R model, Equation 29), the extracellular dopamine concentration 
for the dopamine release rates 6-120 pulse/s was calculated according to the 
developed DAT-R model. The calculation of the extracellular dopamine 
concentration using DAT-R model demonstrated that the predicted extracellular 
dopamine concentration was 81.8% to 102.3% from physiological, 22nM, basal 
extracellular dopamine concentration at all tested dopamine release rates. 
For example, the extracellular dopamine concentration was predicted to be     
18.0 nM,  23.7 nM, and 21.3 nM for the dopamine release rates 6 pulse/s, 10 
pulse/s, and 120 pulse/s respectively (Table 12). Further, the extracellular 
dopamine concentration deviation was calculated to be from 0.13% to 1.38 % 
according to the DAT-R model. This is significantly lower comparing with the 
deviation from 0.15% to 12.8% according to the kinetic (DAT) model.  Thus, the 
feedback component of DAT-R model provided improved stability and reduced 
the distortion to the dopamine concentration control. From a physiological 
perspective, it is expected that such system characteristics would be an attribute 
to the evolved dopaminergic system.  
DAT-R model computes feedback as a function of the percent of receptors 
that are bound by dopamine. The mathematical approach for this feedback 
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modeling was postulated in Tallarida’s mathematical work and was shown to be 
very valuable in this computational study as well. There are several possible 
biochemical mechanisms responsible for the feedback: Adenyl Cyclase 
stimulation; G-protein-coupled receptor activation. Computational feedback  
modeling does not attempt to explain the nature of the feedback mechanism.  
The modeling purpose is to provide a quantitative characteristic to the feedback. 
The feedback was modeled as a function of dopamine receptor occupancy by 
dopamine using linear regression approach. The linear regression analysis was 
used to evaluate the relationship between two variables:  receptor occupancy by 
dopamine (independent variable) and feedback (dependent variable). The 
statistical analysis demonstrated a good linear relationship between the receptor 
occupancy and feedback (R2 =0.986).  
As it was discussed, the presented DAT-R model integrates the uptake, 
release, and feedback mechanisms responsible for the extracellular dopamine 
concentration control. DAT-R model equation allows computational prediction of  
extracellular dopamine concentration change in the range of dopamine receptor 
occupancy from 0 to 1.0. Theoretically, dopamine receptor occupancy by 
dopamine would be equal zero under conditions of high antagonist concentration; 
the dopamine receptor occupancy by dopamine would be equal 1.0 under 
conditions of high dopamine/dopamine agonist concentration. Computational 
data generated by DAT-R model predicted a decrease in the extracellular 
dopamine concentration to 70.8% vs. the basal dopamine concentration if the 
dopamine receptor is fully occupied by dopamine. The increase in the 
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extracellular dopamine concentration up to 438.8% vs. the basal dopamine 
concentration was predicted if dopamine receptor occupancy by dopamine would 
be equal to zero. Thus, the model simulation data demonstrated that DAT-R 
predicted trend for the extracellular dopamine concentration change was 
consistent with the theoretically expected and the experimentally observed 
dopamine system outcomes.    
There are at least two distinct families of dopamine receptors involved into 
the extracellular dopamine concentration control, D2 and D1 - receptors.            
The review of the experimental literature suggested that presynaptic dopamine 
concentration control is mediated by high affinity D2 receptors (autoreceptors). 
The role of D1 receptors remains to be investigated, the current experimental 
data suggests that high affinity D1 receptors are involved in postsynaptic control 
of dopamine concentration. D1 postsynaptic receptor activity is usually observed 
when D1 are fully occupied [43, 47, 63, 106].   The next modeling step was to 
develop and test model considering the involvement of both presynaptic D2 and 
postsynaptic D1 receptors into the extracellular dopamine concentration control. 
For the modeling purposes, the following assumptions were made;   the linear 
regression equation (Equation 28) is the same for both D2 and D1 receptors; D1 
receptor control is present only when D2 receptors are fully (0.7) occupied by 
dopamine; D1 high affinity receptors are consisting 35% from all D1 postsynaptic 
receptors. The model considering feedback mediated by both postsynaptic and 
presynaptic receptors is DAT-RD2RD1 model (Equation 32).     By model 
assumption D1 receptors mediate feedback when D2 receptor occupancy by 
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dopamine is equal or greater 0.7. Thus, Equation 32 was used to calculate  
changes in the extracellular dopamine concentration as dopamine receptor 
occupancy was changed from 0.7 to 1.0.  DAT-RD2RD1 predicted that the 
decrease in extracellular dopamine concentration was as low as 60.7% from  
basal dopamine concentration when dopamine receptor occupancy was equal to 
1.0. This is 10.1% lower vs. the decrease predicted by DAT-R model.    
The final step in the computational evaluation of the developed DAT-R 
and DAT-RD2 RD1 models was to test model performance to predict the 
extracellular dopamine concentration under the conditions equivalent to the 
presence of agonists/antagonists in dopaminergic system. Under these 
conditions the dopamine system response is to settle to a new equilibrium state 
for the extracellular dopamine concentration. The new equilibrium state was 
calculated for the conditions simulating addition either of D2 selective 
antagonists/agonists or D1 selective antagonist/agonists. To evaluate the 
developed model performance, a new equilibrium state computationally predicted 
for the extracellular dopamine concentration was compared with the 
experimentally observed extracellular dopamine concentrations.  
Overall, the equilibrium dopamine concentration changes in the presence 
of agonists/antagonists vs. basal state predicted by developed models were 
consistent with the expected trend, i.e. the increase in the dopamine 
concentration in the presence of antagonists and the decrease in the dopamine 
concentration in the presence of agonists. However, there were important 
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differences in the computed extracellular dopamine concentration changes by 
DAT-R or DAT-RD2RD1  models.  
The comparison of the experimentally available literature data with the 
model computed results demonstrated that DAT-RD2 RD1 model most accurately 
predicted the new state of the equilibrium dopamine concentration for the 
scenarios of the D2 antagonist addition to the system (Table13).  DAT-RD2 RD1 
model predicted the change in the extracellular dopamine concentration from 
202.6% to 260.2% as Haloperidol concentration was increased from 0.003 µM to 
1.00 µM. Without feedback mediated by D1 receptors, the extracellular dopamine 
concentration would be as high as 435.9% vs. basal at Haloperidol concentration 
equal to 1.000 µM. This high increase in extracellular dopamine concentration 
was not observed experimentally. Therefore, DAT-RD2 RD1 model adequately 
addresses the involvement of both D2 and D1 receptor feedback in control of the 
extracellular dopamine concentration in the presence of D2 antagonists. The 
significant implication on the extracellular dopamine concentration of the 
feedback mediated by both D2 and D1 receptor was suggested in the published 
experimental data [63, 70, 77, 85, 86].  
There was no significant difference in the predicted equilibrium 
extracellular dopamine concentration in the presence of Quinpirole, D2 agonist, 
according to either DAT-R or DAT-RD2 RD1 models (Table 15).      
The equilibrium dopamine concentration in the presence of either D1 
agonists or D1 antagonists was more accurately described by DAT-R model.  
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In case of D1 agonists/agonists, feedback in DAT-R model is a function of D1 
occupancy by agonists. The computational observation that the DAT-R model 
had a better predictive performance when compared to the DAT-RD2RD1 model 
suggested that D2 receptor feedback is not responsible for control of  
extracellular dopamine concentration under conditions of D1 receptor activation 
by D1 agonists/agonists (Tables 14, 16).  Interestingly the DAT-R model was able 
to predict correctly the increase in extracellular dopamine concentration under a 
low concentration of A-77636, D1 agonist.  This increase was reported but not 
explained in the published experimental data [77].  Thus the computational 
modeling value was shown not only in the model’s ability to produce data in  
accordance with the experimental data but also to predict system outcomes 
which are rather difficult to be foreseen experimentally.      
In conclusion, this thesis introduced a new quantitative model of  
extracellular dopamine concentration control. This model proposes a single 
model which integrates the known mechanisms involved into the dopaminergic 
system control: dopamine release, DAT uptake, and receptor feedback into one 
system.  Feedback mediated by both D2 and D1 receptors was considered in the 
model.  The model was developed using average parameters for dopaminergic 
system in rat striatum published in the experimental literature.  By changing the 
value of control parameters, this model can be applied to describe a wide range 
of the dopamine systems if extracellular concentration control is governed by 
release, uptake, and receptor feedback.  
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The computational data generated by kinetic (DAT) and feedback (DAT-R) model 
simulations provided strong computational support to demonstrate that both DAT 
uptake and receptor feedback are necessary components of extracellular 
dopamine concentration control under physiological conditions. 
The model is driven by independent parameters of dopamine release, 
uptake, and feedback (Figure. 19) The presence of each component responsible 
for extracellular dopamine concentration control in single mode enables to 
evaluate dopamine concentration outcomes if parameters for individual or 
multiple components of the dopamine system are changing.    
The developed model appeared to be useful for predicting change in 
extracellular dopamine concentration vs. basal under conditions that simulated 
the presence of the agonists/antagonists presence in the dopamine system. 
These computational predictions might be extremely useful in the field of  
experimental drug research as they help scientists to predict system outcomes 
for conditions which are difficult to test in the laboratory and to determine the 
most interesting conditions to address in experimental research.                  
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APPENDIX 1 
SAS Program for Runge-Kutta Algorithm 
 
 
Reference:    Differential Equations and Linear Algebra, C.Edwards  
D.Penney. Prentice-Hall, Inc. 2001, pages 128-135.  
 
Description:  To solve differential equations of type dy/dx=f(x,y) 
 
Parameters:  x0-initial x; x_stp - final x;  h- increment by x; 
y0-initial y; equation- equation f(y,x) 
 
    
 
%MACRO RUNGEKUT_TST (x0, x_stp, h, y0, equation); 
 
 data _null_; 
 nn=(&x_stp-&x0)/&h; 
 call symput ('nn', nn); 
 run; 
 
 data coeff; 
 x_r=&x0; 
 y_r=&y0; 
 
     %do i=1 %to &nn; 
 
        xx_r=x_r; yy_r=y_r; 
        k1=&equation; 
 
        xx_r=x_r+0.5*&h; yy_r=y_r+0.5*&h*k1; 
        k2=&equation; 
 
        xx_r=x_r+0.5*&h; yy_r=y_r+0.5*&h*k2; 
        k3=&equation; 
        xx_r=x_r+&h; yy_r=y_r+&h*k3; 
        k4=&equation; 
 
        y_r=y_r+(&h/6)*(k1+2*k2+2*k3+k4); 
        x_r=x_r+&h; 
 
        output; 
 
      %end; 
 
 run; 
 
 %MEND; 
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Example1:  dy/dx=y+x; x(0)=0 y(0)=1 
 
%RUNGEKUT_TST (0, 1,  0.1, 1, %STR(xx_r+yy_r)) 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 Obs    x_r      y_r         k1         k2         k3         k4 
 
       1    0.1    1.11034    1.00000    1.10000    1.10500    1.21050 
       2    0.2    1.24281    1.21034    1.32086    1.32638    1.44298 
       3    0.3    1.39972    1.44281    1.56495    1.57105    1.69991 
       4    0.4    1.58365    1.69972    1.83470    1.84145    1.98386 
       5    0.5    1.79744    1.98365    2.13283    2.14029    2.29768 
       6    0.6    2.04424    2.29744    2.46231    2.47056    2.64450 
       7    0.7    2.32750    2.64424    2.82645    2.83556    3.02779 
       8    0.8    2.65108    3.02750    3.22888    3.23895    3.45140 
       9    0.9    3.01920    3.45108    3.67363    3.68476    3.91956 
      10    1.0    3.43656    3.91920    4.16516    4.17746    4.43695    
 
      
 
 
 Example2:  dy/dx=y2+x2 x(0)=0 y(0)=1, h=0.1 
 
%RUNGEKUT_TST (0, 1, 0.1, 1, %STR(xx_r**2+yy_r**2)) 
 
 
 
 
Example3: dy/dx=y2+x2; x(0)=0 y(0)=1, h=0.05 
 
%RUNGEKUT_TST (0, 1, 0.05, 1, %STR(xx_r**2+yy_r**2)) 
 
  
 
 
Example4: dy/dx=5y-6e-x; x(0)=0 y(0)=1, h=0.2 
 
 
Obs    x_r      y_r         k1         k2           k3          k4 
 
      1    0.1      1.111      1.000      1.105       1.12        1.25 
      2    0.2      1.253      1.245      1.400       1.42        1.61 
      3    0.3      1.440      1.610      1.841       1.87        2.16 
      4    0.4      1.696      2.163      2.518       2.57        3.04 
      5    0.5      2.067      3.037      3.617       3.73        4.53 
      6    0.6      2.644     4.522      5.561       5.80       7.37 
      7    0.7      3.652      7.350      9.491      10.15       13.88 
      8    0.8      5.842     13.829     19.430      21.94       34.82 
      9    0.9     14.022     34.769     58.186      77.31      185.03 
     10    1.0    735.099    197.421    571.773    1816.55    38290.56 
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Example 3:  dy/dx=5y-6e-x; x(0)=0 y(0)=1, h=0.2 
 
%RUNGEKUT_TST (0, 4, 0.2, 1, %STR(5*yy_r-6*EXP(-xx_r))) 
 
 
Example5: dv/dt=f(t,v)=9.8-0.00016(100v+10v2+v3); v(0)=0 t(0)=0, h=0.1 
 
%RUNGEKUT_TST  
(0, 20, 0.1, 0, %STR(9.8-0.00016*(100*yy_r+10*yy_r**2+yy_r**3))) 
Example5: dv/dt=f(t,v)=9.8-0.00016(100v+10v2+v3); v(0)=0 t(0)=0, h=0.1 
 
%RUNGEKUT_TST  
(0, 20, 0.1, 0, %STR(9.8-0.00016*(100*yy_r+10*yy_r**2+yy_r**3))) 
Example5: dv/dt=f(t,v)=9.8-0.00016(100v+10v2+v3); v(0)=0 t(0)=0, h=0.1 
 
%RUNGEKUT_TST  
(0, 20, 0.1, 0, %STR(9.8-0.00016*(100*yy_r+10*yy_r**2+yy_r**3))) 
 
 
 
 
 
 
 
 
Obs   x_r          y_r           k1           k2           k3           k4 
 
  1   0.2         0.82        -1.00        -0.93        -0.89        -0.81 
  2   0.4         0.67        -0.82        -0.76        -0.74        -0.67 
  3   0.6         0.54        -0.68        -0.63        -0.61        -0.56 
  4   0.8         0.44        -0.57        -0.54        -0.53        -0.50 
  5   1.        0.33        -0.5         -0.51        -0.51        -0.53
  6   1.2         0.21        -0.53        -0.59        -0.62        -0.75 
  7   1.4         0.00        -0.75        -0.96        -1.06        -1.48 
 8   1.6        -0.46        -1.47        -2.06        -2.36        -3.56 
  9   1.8        -1.63        -3.51        -5.15        -5.97        -9.27 
 10   2.0        -4.72       -9.13       -13.60       -15.84       -24.79 
 11   2.2       -13.04       -24.42       -36.55       -42.62       -66.89 
 12   2.4       -35.53       -65.88       -98.76      -115.19      -180.95 
 13   2.6       -96.41      -178.22      -267.27      -311.80      -489.92 
 14   2.8      -261.25      -482.49      -723.70      -844.30     -1326.72 
15   3.0      -707.67     -1306.62     -1959.89     -2286.53     -3593.08 
 16   3.2     -1916.69     -3538.64     -5307.93     -6192.57     -9731.15 
 17   3.4     -5191.12     -9583.71    -14375.55    -16771.46    -26355.13 
 18   3.6   -14059.35    -25955.82    -38933.70    -45422.65    -71378.43
 19   3.8    -38077.47    -70296.94   -105445.39   -123019.62   -193316.52 
 20   4.0   -103126.53   -190387.49   -285581.22   -333178.08   -523565.55 
 
 
Example5:  dv/dt=f(t,v)=9.8-0.00016(100v+10v2+v3); v(0)=0 t(0)=0, h=0.1 
 
%RUNGEKUT_TST (0, 20, 0.1, 0, %STR(9.8-
0.00016*(100*yy_r+10*yy_r**2+yy_r**3))) 
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Obs    x_r      y_r         k1         k2         k3         k4 
 
       1    0.1     0.9792    9.80000    9.79176    9.79176    9.78265 
       2    0.2     1.9564    9.78265    9.77255    9.77256    9.76138 
       3    0.3     2.9313    9.76138    9.74899    9.74901    9.73532 
       4    0.4     3.9033    9.73532    9.72023    9.72025    9.70365 
       5    0.5     4.8718    9.70366    9.68545    9.68548    9.66557 
       6    0.6     5.8362    9.66558    9.64387    9.64392    9.62032 
       7    0.7     6.7956    9.62032    9.59474    9.59481    9.56717 
       8    0.8     7.7493    9.56717    9.53738    9.53748    9.50547 
       9    0.9     8.6964    9.50547    9.47116    9.47129    9.43462 
      10    1.0     9.6359    9.43463    9.39552    9.39569    9.35411 
      11    1.1    10.5669    9.35411    9.30998    9.31020    9.26349 
      12    1.2    11.4883    9.26349    9.21415    9.21442    9.16242 
      13    1.3    12.3990    9.16242    9.10772    9.10806    9.05065 
      14    1.4    13.2980    9.05065    8.99050    8.99091    8.92803 
      15    1.5    14.1842    8.92804    8.86240    8.86290    8.79453 
      16    1.6    15.0566    8.79454    8.72344    8.72403    8.65023 
      17    1.7    15.9139    8.65024    8.57375    8.57444    8.49532 
      18    1.8    16.7553    8.49533    8.41359    8.41439    8.33009 
      19    1.9    17.5796    8.33011    8.24330    8.24423    8.15498 
      20    2.0    18.3860    8.15500    8.06337    8.06442    7.97049 
 APPENDIX 2 
Extracelular Dopamine Concentration calculated by SAS Program for 
Kinetic Dopamine Model 
 
 
Reference:   Wightman R.M., Amatore C., Engstrom C., Hale P.D., Kristensen E.W., 
Kuhr W. G. and May L.J. Real-Time Characterization of Dopamine 
Overflow and Uptake and Rat Striatum. Neuroscience, 25(2): 513-523, 
1988.  
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To assure the computational accuracy of SAS program written for DAT control, the 
extracellular dopamine concentration control by DAT uptake was calculated and 
compared with Wightman R.M et al., data for the extracellular dopamine concentration. 
Dopamine input was modeled at frequency stimulation from 5 to 60 Hz, with stimulation 
duration equal to 2 sec, and free dopamine release of 0.125 µM per pulse. Dopamine 
concentration profile is shown for 5 sec.  
 
SAS program and Wightman R.M et al. results were identical. 
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